{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:29:16Z","timestamp":1787066956907,"version":"build-2736575974"},"reference-count":282,"publisher":"Bentham Science Publishers Ltd.","issue":"25","funder":[{"DOI":"10.13039\/100007471","name":"Yunnan Applied Basic Research Project Foundation","doi-asserted-by":"publisher","award":["2017FB035"],"award-info":[{"award-number":["2017FB035"]}],"id":[{"id":"10.13039\/100007471","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"Chinese National Natural Science Foundation","doi-asserted-by":"publisher","award":["81760648"],"award-info":[{"award-number":["81760648"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"Chinese National Natural Science Foundation","doi-asserted-by":"publisher","award":["31670776"],"award-info":[{"award-number":["31670776"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"Chinese National Natural Science Foundation","doi-asserted-by":"publisher","award":["31460571"],"award-info":[{"award-number":["31460571"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2019,10,16]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Neurodegenerative diseases, such as Alzheimer\u2019s disease, Parkinson\u2019s disease, and cerebral ischemic stroke, impose enormous socio-economic burdens on both patients and health-care systems. However, drugs targeting these diseases remain unsatisfactory, and hence there is an urgent need for the development of novel and potent drug candidates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Animal toxins exhibit rich diversity in both proteins and peptides, which play vital roles in biomedical drug development. As a molecular tool, animal toxin peptides have not only helped clarify many critical physiological processes but also led to the discovery of novel drugs and clinical therapeutics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Recently, toxin peptides identified from venomous animals, e.g. exenatide, ziconotide, Hi1a, and PcTx1 from spider venom, have been shown to block specific ion channels, alleviate inflammation, decrease protein aggregates, regulate glutamate and neurotransmitter levels, and increase neuroprotective factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Thus, components of venom hold considerable capacity as drug candidates for the alleviation or reduction of neurodegeneration. This review highlights studies evaluating different animal toxins, especially peptides, as promising therapeutic tools for the treatment of different neurodegenerative diseases and disorders.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0929867325666181031122438","type":"journal-article","created":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T07:58:46Z","timestamp":1540972726000},"page":"4749-4774","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Animal Venom Peptides as a Treasure Trove for New Therapeutics Against Neurodegenerative Disorders"],"prefix":"10.2174","volume":"26","author":[{"given":"Xinwang","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Anatomy and Histology & Embryology, Faculty of Basic Medical Science, Kunming Medical University, Kunming 650500, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Chemistry in Ethnic Medicine Resource, State Ethnic Affairs Commission & Ministry of Education, School of Ethnomedicine and Ethnopharmacy, Yunnan Minzu University, Kunming 650500, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyun","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Anatomy and Histology & Embryology, Faculty of Basic Medical Science, Kunming Medical University, Kunming 650500, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eng-Ang","family":"Ling","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","year":"1993","unstructured":"The Huntington\u2019s Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 1993,72(6),971-983","journal-title":"Cell"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1126\/science.1691865","volume":"248","author":"Sisodia S.S.","year":"1990","unstructured":"Sisodia S.S.; Koo E.H.; Beyreuther K.; Unterbeck A.; Price D.L.; Evidence that beta-amyloid protein in Alzheimer\u2019s disease is not derived by normal processing. Science 1990,248(4954),492-495","journal-title":"Science"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1126\/science.1132813","volume":"314","author":"Roberson E.D.","year":"2006","unstructured":"Roberson E.D.; Mucke L.; 100 years and counting: prospects for defeating Alzheimer\u2019s disease. Science 2006,314(5800),781-784","journal-title":"Science"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1056\/NEJM199810083391506","volume":"339","author":"Lang A.E.","year":"1998","unstructured":"Lang A.E.; Lozano A.M.; Parkinson\u2019s disease. First of two parts. N Engl J Med 1998,339(15),1044-1053","journal-title":"N Engl J Med"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.3233\/JAD-2012-129045","volume":"33","author":"Perry G.","year":"2013","unstructured":"Perry G.; Zhu X.; Smith M.A.; Sorensen A.; Avila J.; Preface. Alzheimer\u2019s disease: advances for a new century. J Alzheimers Dis 2013,33(Suppl. 1),S1","journal-title":"J Alzheimers Dis"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"77sr1","DOI":"10.1126\/scitranslmed.3002369","volume":"3","author":"Holtzman D.M.","year":"2011","unstructured":"Holtzman D.M.; Morris J.C.; Goate A.M.; Alzheimer\u2019s disease: the challenge of the second century. Sci Transl Med 2011,3(77),77sr1","journal-title":"Sci Transl Med"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1126\/science.1132814","volume":"314","author":"Goedert M.","year":"2006","unstructured":"Goedert M.; Spillantini M.G.; A century of Alzheimer\u2019s disease. Science 2006,314(5800),777-781","journal-title":"Science"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/B978-0-12-394309-5.00006-7","volume":"298","author":"Kalogeris T.","year":"2012","unstructured":"Kalogeris T.; Baines C.P.; Krenz M.; Korthuis R.J.; Cell biology of ischemia\/reperfusion injury. Int Rev Cell Mol Biol 2012,298,229-317","journal-title":"Int Rev Cell Mol Biol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.freeradbiomed.2012.11.014","volume":"62","author":"Yan M.H.","year":"2013","unstructured":"Yan M.H.; Wang X.; Zhu X.; Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease. Free Radic Biol Med 2013,62,90-101","journal-title":"Free Radic Biol Med"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/cdd.2008.150","volume":"16","author":"Kroemer G.","year":"2009","unstructured":"Kroemer G.; Galluzzi L.; Vandenabeele P.; Abrams J.; Alnemri E.S.; Baehrecke E.H.; Blagosklonny M.V.; El-Deiry W.S.; Golstein P.; Green D.R.; Hengartner M.; Knight R.A.; Kumar S.; Lipton S.A.; Malorni W.; Nu\u00f1ez G.; Peter M.E.; Tschopp J.; Yuan J.; Piacentini M.; Zhivotovsky B.; Melino G.; Nomenclature Committee on Cell Death 2009. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 2009,16(1),3-11","journal-title":"Cell Death Differ"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/bjc.1972.33","volume":"26","author":"Kerr J.F.","year":"1972","unstructured":"Kerr J.F.; Wyllie A.H.; Currie A.R.; Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972,26(4),239-257","journal-title":"Br J Cancer"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"Elmore S.","year":"2007","unstructured":"Elmore S.; Apoptosis: a review of programmed cell death. Toxicol Pathol 2007,35(4),495-516","journal-title":"Toxicol Pathol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/cc2950","volume":"9","author":"Zhang X.","year":"2005","unstructured":"Zhang X.; Chen Y.; Jenkins L.W.; Kochanek P.M.; Clark R.S.; Bench-to-bedside review: apoptosis\/programmed cell death triggered by traumatic brain injury. Crit Care 2005,9(1),66-75","journal-title":"Crit Care"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1126\/science.281.5381.1312","volume":"281","author":"Thornberry N.A.","year":"1998","unstructured":"Thornberry N.A.; Lazebnik Y.; Caspases: enemies within. Science 1998,281(5381),1312-1316","journal-title":"Science"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1097-2765(02)00482-3","volume":"9","author":"Shi Y.","year":"2002","unstructured":"Shi Y.; Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell 2002,9(3),459-470","journal-title":"Mol Cell"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.toxlet.2006.06.005","volume":"166","author":"Kanno S.","year":"2006","unstructured":"Kanno S.; Tomizawa A.; Ohtake T.; Koiwai K.; Ujibe M.; Ishikawa M.; Naringenin-induced apoptosis via activation of NF-kappaB and necrosis involving the loss of ATP in human promyeloleukemia HL-60 cells. Toxicol Lett 2006,166(2),131-139","journal-title":"Toxicol Lett"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.2169\/internalmedicine.52.1118","volume":"52","author":"Araya J.","year":"2013","unstructured":"Araya J.; Hara H.; Kuwano K.; Autophagy in the pathogenesis of pulmonary disease. Intern Med 2013,52(20),2295-2303","journal-title":"Intern Med"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cell.2007.12.018","volume":"132","author":"Levine B.","year":"2008","unstructured":"Levine B.; Kroemer G.; Autophagy in the pathogenesis of disease. Cell 2008,132(1),27-42","journal-title":"Cell"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.cellsig.2013.11.028","volume":"26","author":"Booth L.A.","year":"2014","unstructured":"Booth L.A.; Tavallai S.; Hamed H.A.; Cruickshanks N.; Dent P.; The role of cell signalling in the crosstalk between autophagy and apoptosis. Cell Signal 2014,26(3),549-555","journal-title":"Cell Signal"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000487486","volume":"61","author":"Lin W.","year":"2019","unstructured":"Lin W.; Xu G.; Autophagy: a role in the apoptosis, survival, inflammation, and development of the retina. Ophthalmic Res 2019,61(2),65-72","journal-title":"Ophthalmic Res"},{"key":"ref=21","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201800332","volume":"7","author":"He G.","year":"2018","unstructured":"He G.; Ma Y.; Zhu Y.; Yong L.; Liu X.; Wang P.; Liang C.; Yang C.; Zhao Z.; Hai B.; Pan X.; Liu Z.; Liu X.; Mao C.; Cross talk between autophagy and apoptosis contributes to ZnO nanoparticle-induced human osteosarcoma cell death. Adv Healthc Mater 2018,7(17)","journal-title":"Adv Healthc Mater"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jcmgh.2016.05.007","volume":"2","author":"Sendler M.","year":"2016","unstructured":"Sendler M.; Mayerle J.; Lerch M.M.; Necrosis, apoptosis, necroptosis, pyroptosis: it matters how acinar cells die during pancreatitis. Cell Mol Gastroenterol Hepatol 2016,2(4),407-408","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"16101","DOI":"10.1038\/cddiscovery.2016.101","volume":"3","author":"Lekshmi A.","year":"2017","unstructured":"Lekshmi A.; Varadarajan S.N.; Lupitha S.S.; Indira D.; Mathew K.A.; Chandrasekharan Nair A.; Nair M.; Prasad T.; Sekar H.; Gopalakrishnan A.K.; Murali A.; Santhoshkumar T.R.; A quantitative real-time approach for discriminating apoptosis and necrosis. Cell Death Discov 2017,3,16101","journal-title":"Cell Death Discov"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2174\/1567202043362018","volume":"1","author":"Ekshyyan O.","year":"2004","unstructured":"Ekshyyan O.; Aw T.Y.; Apoptosis: a key in neurodegenerative disorders. Curr Neurovasc Res 2004,1(4),355-371","journal-title":"Curr Neurovasc Res"},{"key":"ref=25","first-page":"219","volume":"9","author":"Linnik M.D.","year":"1996","unstructured":"Linnik M.D.; Role of apoptosis in acute neurodegenerative disorders. Restor Neurol Neurosci 1996,9(4),219-225","journal-title":"Restor Neurol Neurosci"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/0022-510X(95)00336-Z","volume":"137","author":"Mochizuki H.","year":"1996","unstructured":"Mochizuki H.; Goto K.; Mori H.; Mizuno Y.; Histochemical detection of apoptosis in Parkinson\u2019s disease. J Neurol Sci 1996,137(2),120-123","journal-title":"J Neurol Sci"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0896-6273(93)90180-Y","volume":"11","author":"Tymianski M.","year":"1993","unstructured":"Tymianski M.; Wallace M.C.; Spigelman I.; Uno M.; Carlen P.L.; Tator C.H.; Charlton M.P.; Cell-permeant Ca2+ chelators reduce early excitotoxic and ischemic neuronal injury in vitro and in vivo. Neuron 1993,11(2),221-235","journal-title":"Neuron"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0006-8993(03)02270-4","volume":"967","author":"Yoneda S.","year":"2003","unstructured":"Yoneda S.; Tanaka E.; Goto W.; Ota T.; Hara H.; Topiramate reduces excitotoxic and ischemic injury in the rat retina. Brain Res 2003,967(1-2),257-266","journal-title":"Brain Res"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.neuroscience.2016.12.008","volume":"343","author":"Mazzone G.L.","year":"2017","unstructured":"Mazzone G.L.; Veeraraghavan P.; Gonzalez-Inchauspe C.; Nistri A.; Uchitel O.D.; ASIC channel inhibition enhances excitotoxic neuronal death in an in vitro model of spinal cord injury. Neuroscience 2017,343,398-410","journal-title":"Neuroscience"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.expneurol.2016.05.024","volume":"282","author":"Pansiot J.","year":"2016","unstructured":"Pansiot J.; Pham H.; Dalous J.; Chevenne D.; Colella M.; Schwendimann L.; Fafouri A.; Mairesse J.; Moretti R.; Schang A.L.; Charriaut-Marlangue C.; Gressens P.; Baud O.; Glial response to 17\u03b2-estradiol in neonatal rats with excitotoxic brain injury. Exp Neurol 2016,282,56-65","journal-title":"Exp Neurol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/sj.jcbfm.9600455","volume":"27","author":"Tekk\u00f6k S.B.","year":"2007","unstructured":"Tekk\u00f6k S.B.; Ye Z.; Ransom B.R.; Excitotoxic mechanisms of ischemic injury in myelinated white matter. J Cereb Blood Flow Metab 2007,27(9),1540-1552","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.molbrainres.2005.04.013","volume":"138","author":"Yu C.G.","year":"2005","unstructured":"Yu C.G.; Yezierski R.P.; Activation of the ERK1\/2 signaling cascade by excitotoxic spinal cord injury. Brain Res Mol Brain Res 2005,138(2),244-255","journal-title":"Brain Res Mol Brain Res"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"28894","DOI":"10.1074\/jbc.M503090200","volume":"280","author":"Kushnareva Y.E.","year":"2005","unstructured":"Kushnareva Y.E.; Wiley S.E.; Ward M.W.; Andreyev A.Y.; Murphy A.N.; Excitotoxic injury to mitochondria isolated from cultured neurons. J Biol Chem 2005,280(32),28894-28902","journal-title":"J Biol Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"530","DOI":"10.3389\/fneur.2017.00530","volume":"8","author":"Irimia A.","year":"2017","unstructured":"Irimia A.; Goh S.M.; Wade A.C.; Patel K.; Vespa P.M.; Van Horn J.D.; Traumatic brain injury severity, neuropathophysiology, and clinical outcome: insights from multimodal neuroimaging. Front Neurol 2017,8,530","journal-title":"Front Neurol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.anclin.2016.04.011","volume":"34","author":"Quillinan N.","year":"2016","unstructured":"Quillinan N.; Herson P.S.; Traystman R.J.; Neuropathophysiology of brain injury. Anesthesiol Clin 2016,34(3),453-464","journal-title":"Anesthesiol Clin"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00424-010-0809-1","volume":"460","author":"Lau A.","year":"2010","unstructured":"Lau A.; Tymianski M.; Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch 2010,460(2),525-542","journal-title":"Pflugers Arch"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cophys.2017.12.003","volume":"2","author":"Wollmuth L.P.","year":"2018","unstructured":"Wollmuth L.P.; Ion permeation in ionotropic glutamate receptors: still dynamic after all these years. Curr Opin Physiol 2018,2,36-41","journal-title":"Curr Opin Physiol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.mcn.2018.05.002","volume":"91","author":"Scheefhals N.","year":"2018","unstructured":"Scheefhals N.; MacGillavry H.D.; Functional organization of postsynaptic glutamate receptors. Mol Cell Neurosci 2018,91,82-94","journal-title":"Mol Cell Neurosci"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1080\/00207454.2017.1387112","volume":"128","author":"Lian Y.N.","year":"2018","unstructured":"Lian Y.N.; Lu Q.; Chang J.L.; Zhang Y.; The role of glutamate and its receptors in central nervous system in stress-induced hyperalgesia. Int J Neurosci 2018,128(3),283-290","journal-title":"Int J Neurosci"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/10253890.2016.1174848","volume":"19","author":"Chomova M.","year":"2016","unstructured":"Chomova M.; Zitnanova I.; Look into brain energy crisis and membrane pathophysiology in ischemia and reperfusion. Stress 2016,19(4),341-348","journal-title":"Stress"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/ana.410130103","volume":"13","author":"Raichle M.E.","year":"1983","unstructured":"Raichle M.E.; The pathophysiology of brain ischemia. Ann Neurol 1983,13(1),2-10","journal-title":"Ann Neurol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1046\/j.1440-1681.2000.03326.x","volume":"27","author":"Pepe S.","year":"2000","unstructured":"Pepe S.; Mitochondrial function in ischaemia and reperfusion of the ageing heart. Clin Exp Pharmacol Physiol 2000,27(9),745-750","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"3550","DOI":"10.1523\/JNEUROSCI.4378-10.2011","volume":"31","author":"Azarias G.","year":"2011","unstructured":"Azarias G.; Perreten H.; Lengacher S.; Poburko D.; Demaurex N.; Magistretti P.J.; Chatton J.Y.; Glutamate transport decreases mitochondrial pH and modulates oxidative metabolism in astrocytes. J Neurosci 2011,31(10),3550-3559","journal-title":"J Neurosci"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1134\/S0006297914020084","volume":"79","author":"Surin A.M.","year":"2014","unstructured":"Surin A.M.; Gorbacheva L.R.; Savinkova I.G.; Sharipov R.R.; Khodorov B.I.; Pinelis V.G.; Study on ATP concentration changes in cytosol of individual cultured neurons during glutamate-induced deregulation of calcium homeostasis. Biochemistry (Mosc) 2014,79(2),146-157","journal-title":"Biochemistry (Mosc)"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"4680","DOI":"10.1074\/jbc.272.8.4680","volume":"272","author":"Garland J.M.","year":"1997","unstructured":"Garland J.M.; Halestrap A.; Energy metabolism during apoptosis. Bcl-2 promotes survival in hematopoietic cells induced to apoptose by growth factor withdrawal by stabilizing a form of metabolic arrest. J Biol Chem 1997,272(8),4680-4688","journal-title":"J Biol Chem"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"38505","DOI":"10.1074\/jbc.M505223200","volume":"280","author":"Miyamoto S.","year":"2005","unstructured":"Miyamoto S.; Howes A.L.; Adams J.W.; Dorn G.W.; Brown J.H.; Ca2+ dysregulation induces mitochondrial depolarization and apoptosis: role of Na+\/Ca2+ exchanger and AKT. J Biol Chem 2005,280(46),38505-38512","journal-title":"J Biol Chem"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11010-009-0104-7","volume":"330","author":"Wang Z.","year":"2009","unstructured":"Wang Z.; Wang W.; Shao Z.; Gao B.; Li J.; Ma J.; Li J.; Che H.; Zhang W.; Eukaryotic expression and purification of anti-epilepsy peptide of Buthus martensii Karsch and its protein interactions. Mol Cell Biochem 2009,330(1-2),97-104","journal-title":"Mol Cell Biochem"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/j.1460-9568.2010.07298.x","volume":"32","author":"Su\u00e1rez F.","year":"2010","unstructured":"Su\u00e1rez F.; Zhao Q.; Monaghan D.T.; Jane D.E.; Jones S.; Gibb A.J.; Functional heterogeneity of NMDA receptors in rat substantia nigra pars compacta and reticulata neurones. Eur J Neurosci 2010,32(3),359-367","journal-title":"Eur J Neurosci"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1046\/j.1440-1681.2003.03930.x","volume":"30","author":"Touyz R.M.","year":"2003","unstructured":"Touyz R.M.; Tabet F.; Schiffrin E.L.; Redox-dependent signalling by angiotensin II and vascular remodelling in hypertension. Clin Exp Pharmacol Physiol 2003,30(11),860-866","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/glia.22594","volume":"62","author":"Lapp D.W.","year":"2014","unstructured":"Lapp D.W.; Zhang S.S.; Barnstable C.J.; Stat3 mediates LIF-induced protection of astrocytes against toxic ROS by upregu-lating the UPC2 mRNA pool. Glia 2014,62(2),159-170","journal-title":"Glia"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.mehy.2004.03.021","volume":"63","author":"Wiseman A.","year":"2004","unstructured":"Wiseman A.; Dietary alkyl thiol free radicals (RSS) can be as toxic as reactive oxygen species (ROS). Med Hypotheses 2004,63(4),667-670","journal-title":"Med Hypotheses"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.chembiol.2018.05.004","volume":"25","author":"Trist B.G.","year":"2018","unstructured":"Trist B.G.; Hare D.J.; Double K.L.; A proposed mechanism for neurodegeneration in movement disorders characterized by metal dyshomeostasis and oxidative stress. Cell Chem Biol 2018,25(7),807-816","journal-title":"Cell Chem Biol"},{"key":"ref=53","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/428010","author":"Gandhi S.","year":"2012","unstructured":"Gandhi S.; Abramov A.Y.; Mechanism of oxidative stress in neurodegeneration. Oxid Med Cell Longev 2012","journal-title":"Oxid Med Cell Longev"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.bbadis.2006.03.008","volume":"1762","author":"Barber S.C.","year":"2006","unstructured":"Barber S.C.; Mead R.J.; Shaw P.J.; Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target. Biochim Biophys Acta 2006,1762(11-12),1051-1067","journal-title":"Biochim Biophys Acta"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1750-3639.2005.tb00512.x","volume":"15","author":"Musiek E.S.","year":"2005","unstructured":"Musiek E.S.; Milne G.L.; McLaughlin B.; Morrow J.D.; Cyclopentenone eicosanoids as mediators of neurodegenera-tion: a pathogenic mechanism of oxidative stress-mediated and cyclooxygenase-mediated neurotoxicity. Brain Pathol 2005,15(2),149-158","journal-title":"Brain Pathol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"S357","DOI":"10.3233\/JAD-2010-100498","volume":"20","author":"Patten D.A.","year":"2010","unstructured":"Patten D.A.; Germain M.; Kelly M.A.; Slack R.S.; Reactive oxygen species: stuck in the middle of neurodegeneration. J Alzheimers Dis 2010,20(Suppl. 2),S357-S367","journal-title":"J Alzheimers Dis"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"6306","DOI":"10.3390\/ijms14036306","volume":"14","author":"Bolisetty S.","year":"2013","unstructured":"Bolisetty S.; Jaimes E.A.; Mitochondria and reactive oxygen species: physiology and pathophysiology. Int J Mol Sci 2013,14(3),6306-6344","journal-title":"Int J Mol Sci"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1126\/science.1232751","volume":"339","author":"Liu Y.","year":"2013","unstructured":"Liu Y.; Imlay J.A.; Cell death from antibiotics without the involvement of reactive oxygen species. Science 2013,339(6124),1210-1213","journal-title":"Science"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.cell.2006.09.024","volume":"127","author":"St-Pierre J.","year":"2006","unstructured":"St-Pierre J.; Drori S.; Uldry M.; Silvaggi J.M.; Rhee J.; J\u00e4ger S.; Handschin C.; Zheng K.; Lin J.; Yang W.; Simon D.K.; Bachoo R.; Spiegelman B.M.; Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 2006,127(2),397-408","journal-title":"Cell"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.cell.2004.10.017","volume":"119","author":"Pham C.G.","year":"2004","unstructured":"Pham C.G.; Bubici C.; Zazzeroni F.; Papa S.; Jones J.; Alvarez K.; Jayawardena S.; De Smaele E.; Cong R.; Beaumont C.; Torti F.M.; Torti S.V.; Franzoso G.; Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell 2004,119(4),529-542","journal-title":"Cell"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1007\/s10620-007-0195-5","volume":"53","author":"Koppisetti S.","year":"2008","unstructured":"Koppisetti S.; Jenigiri B.; Terron M.P.; Tengattini S.; Tamura H.; Flores L.J.; Tan D.X.; Reiter R.J.; Reactive oxygen species and the hypomotility of the gall bladder as targets for the treatment of gallstones with melatonin: a review. Dig Dis Sci 2008,53(10),2592-2603","journal-title":"Dig Dis Sci"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1515\/znc-1997-9-1001","volume":"52","author":"Hippeli S.","year":"1997","unstructured":"Hippeli S.; Elstner E.F.; OH-radical-type reactive oxygen species: a short review on the mechanisms of OH-radical- and peroxynitrite toxicity. Z Natforsch C J Biosci 1997,52(9-10),555-563","journal-title":"Z Natforsch C J Biosci"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/(SICI)1096-9926(199603)53:3<196:AID-TERA7>3.0.CO;2-2","volume":"53","author":"Fantel A.G.","year":"1996","unstructured":"Fantel A.G.; Reactive oxygen species in developmental toxicity: review and hypothesis. Teratology 1996,53(3),196-217","journal-title":"Teratology"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1161\/01.RES.87.3.179","volume":"87","author":"Irani K.","year":"2000","unstructured":"Irani K.; Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ Res 2000,87(3),179-183","journal-title":"Circ Res"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.freeradbiomed.2012.09.016","volume":"62","author":"Dasuri K.","year":"2013","unstructured":"Dasuri K.; Zhang L.; Keller J.N.; Oxidative stress, neurodegeneration, and the balance of protein degradation and protein synthesis. Free Radic Biol Med 2013,62,170-185","journal-title":"Free Radic Biol Med"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"19866","DOI":"10.1038\/srep19866","volume":"6","author":"Yang X.","year":"2016","unstructured":"Yang X.; Wang Y.; Zhang Y.; Lee W.H.; Zhang Y.; Rich diversity and potency of skin antioxidant peptides revealed a novel molecular basis for high-altitude adaptation of amphibians. Sci Rep 2016,6,19866","journal-title":"Sci Rep"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1021\/pr200782u","volume":"11","author":"Yang X.","year":"2012","unstructured":"Yang X.; Lee W.H.; Zhang Y.; Extremely abundant antimicrobial peptides existed in the skins of nine kinds of Chinese odorous frogs. J Proteome Res 2012,11(1),306-319","journal-title":"J Proteome Res"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1126\/science.290.5493.985","volume":"290","author":"Giasson B.I.","year":"2000","unstructured":"Giasson B.I.; Duda J.E.; Murray I.V.; Chen Q.; Souza J.M.; Hurtig H.I.; Ischiropoulos H.; Trojanowski J.Q.; Lee V.M.; Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 2000,290(5493),985-989","journal-title":"Science"},{"key":"ref=69","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JPD-130230","volume":"3","author":"Dias V.","year":"2013","unstructured":"Dias V.; Junn E.; Mouradian M.M.; The role of oxidative stress in Parkinson\u2019s disease. J Parkinsons Dis 2013,3(4),461-491","journal-title":"J Parkinsons Dis"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5607\/en.2013.22.1.11","volume":"22","author":"Hwang O.","year":"2013","unstructured":"Hwang O.; Role of oxidative stress in Parkinson\u2019s disease. Exp Neurobiol 2013,22(1),11-17","journal-title":"Exp Neurobiol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1007\/s11064-010-0212-5","volume":"35","author":"Baillet A.","year":"2010","unstructured":"Baillet A.; Chanteperdrix V.; Trocm\u00e9 C.; Casez P.; Garrel C.; Besson G.; The role of oxidative stress in amyotrophic lateral sclerosis and Parkinson\u2019s disease. Neurochem Res 2010,35(10),1530-1537","journal-title":"Neurochem Res"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.cellsig.2012.01.008","volume":"24","author":"Ray P.D.","year":"2012","unstructured":"Ray P.D.; Huang B.W.; Tsuji Y.; Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 2012,24(5),981-990","journal-title":"Cell Signal"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S0197-4580(01)00340-2","volume":"23","author":"Butterfield D.A.","year":"2002","unstructured":"Butterfield D.A.; Castegna A.; Lauderback C.M.; Drake J.; Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer\u2019s disease brain contribute to neuronal death. Neurobiol Aging 2002,23(5),655-664","journal-title":"Neurobiol Aging"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.mito.2015.02.001","volume":"21","author":"Mena N.P.","year":"2015","unstructured":"Mena N.P.; Urrutia P.J.; Lourido F.; Carrasco C.M.; N\u00fa\u00f1ez M.T.; Mitochondrial iron homeostasis and its dysfunctions in neurodegenerative disorders. Mitochondrion 2015,21,92-105","journal-title":"Mitochondrion"},{"key":"ref=75","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/175062","author":"Hroudov\u00e1 J.","year":"2014","unstructured":"Hroudov\u00e1 J.; Singh N.; Fi\u0161ar Z.; Mitochondrial dysfunctions in neurodegenerative diseases: relevance to Alzheimer\u2019s disease. BioMed Res Int 2014","journal-title":"BioMed Res Int"},{"key":"ref=76","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/604658","volume":"2015","author":"Zuo L.","year":"2015","unstructured":"Zuo L.; Hemmelgarn B.T.; Chuang C.C.; Best T.M.; The role of oxidative stress-induced epigenetic alterations in amyloid-\u03b2 production in Alzheimer\u2019s Disease. Oxid Med Cell Longev 2015,2015","journal-title":"Oxid Med Cell Longev"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/(SICI)1097-4547(20000215)59:4<528:AID-JNR8>3.0.CO;2-0","volume":"59","author":"Giasson B.I.","year":"2000","unstructured":"Giasson B.I.; Jakes R.; Goedert M.; Duda J.E.; Leight S.; Trojanowski J.Q.; Lee V.M.; A panel of epitope-specific antibodies detects protein domains distributed throughout human alpha-synuclein in Lewy bodies of Parkinson\u2019s disease. J Neurosci Res 2000,59(4),528-533","journal-title":"J Neurosci Res"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1021\/bi047982v","volume":"44","author":"Reynolds M.R.","year":"2005","unstructured":"Reynolds M.R.; Berry R.W.; Binder L.I.; Site-specific nitration and oxidative dityrosine bridging of the tau protein by peroxynitrite: implications for Alzheimer\u2019s disease. Biochemistry 2005,44(5),1690-1700","journal-title":"Biochemistry"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/S0002-9440(10)63462-1","volume":"163","author":"Horiguchi T.","year":"2003","unstructured":"Horiguchi T.; Uryu K.; Giasson B.I.; Ischiropoulos H.; LightFoot, R.; Bellmann, C.; Richter-Landsberg, C.; Lee, V.M.; Trojanowski, J.Q. Nitration of tau protein is linked to neurodegeneration in tauopathies. Am J Pathol 2003,163(3),1021-1031","journal-title":"Am J Pathol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1006\/jmbi.1998.1828","volume":"279","author":"Cordier-Ochsenbein F.","year":"1998","unstructured":"Cordier-Ochsenbein F.; Guerois R.; Russo-Marie F.; Neumann J.M.; Sanson A.; Exploring the folding pathways of annexin I, a multidomain protein. II. Hierarchy in domain folding propensities may govern the folding process. J Mol Biol 1998,279(5),1177-1185","journal-title":"J Mol Biol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1126\/science.181.4096.223","volume":"181","author":"Anfinsen C.B.","year":"1973","unstructured":"Anfinsen C.B.; Principles that govern the folding of protein chains. Science 1973,181(4096),223-230","journal-title":"Science"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1096\/fj.07-099671","volume":"22","author":"Herczenik E.","year":"2008","unstructured":"Herczenik E.; Gebbink M.F.; Molecular and cellular aspects of protein misfolding and disease. FASEB J 2008,22(7),2115-2133","journal-title":"FASEB J"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0959-437X(03)00053-4","volume":"13","author":"Berke S.J.","year":"2003","unstructured":"Berke S.J.; Paulson H.L.; Protein aggregation and the ubiquitin proteasome pathway: gaining the UPPer hand on neurodegen-eration. Curr Opin Genet Dev 2003,13(3),253-261","journal-title":"Curr Opin Genet Dev"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1073\/pnas.0904532106","volume":"107","author":"Friedrich R.P.","year":"2010","unstructured":"Friedrich R.P.; Tepper K.; R\u00f6nicke R.; Soom M.; Westermann M.; Reymann K.; Kaether C.; F\u00e4ndrich M.; Mechanism of amyloid plaque formation suggests an intracellular basis of Abeta pathogenicity. Proc Natl Acad Sci USA 2010,107(5),1942-1947","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.bbrc.2012.08.020","volume":"425","author":"Glenner G.G.","year":"2012","unstructured":"Glenner G.G.; Wong C.W.; Alzheimer\u2019s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. 1984. Biochem Biophys Res Commun 2012,425(3),534-539","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"Polymeropoulos M.H.","year":"1997","unstructured":"Polymeropoulos M.H.; Lavedan C.; Leroy E.; Ide S.E.; Dehejia A.; Dutra A.; Pike B.; Root H.; Rubenstein J.; Boyer R.; Stenroos E.S.; Chandrasekharappa S.; Athanassiadou A.; Papapetropoulos T.; Johnson W.G.; Lazzarini A.M.; Duvoisin R.C.; Di Iorio G.; Golbe L.I.; Nussbaum R.L.; Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science 1997,276(5321),2045-2047","journal-title":"Science"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","volume":"90","author":"Davies S.W.","year":"1997","unstructured":"Davies S.W.; Turmaine M.; Cozens B.A.; DiFiglia M.; Sharp A.H.; Ross C.A.; Scherzinger E.; Wanker E.E.; Mangiarini L.; Bates G.P.; Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 1997,90(3),537-548","journal-title":"Cell"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"DiFiglia M.","year":"1997","unstructured":"DiFiglia M.; Sapp E.; Chase K.O.; Davies S.W.; Bates G.P.; Vonsattel J.P.; Aronin N.; Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 1997,277(5334),1990-1993","journal-title":"Science"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.coph.2009.09.002","volume":"9","author":"Johannsen D.L.","year":"2009","unstructured":"Johannsen D.L.; Ravussin E.; The role of mitochondria in health and disease. Curr Opin Pharmacol 2009,9(6),780-786","journal-title":"Curr Opin Pharmacol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1126\/science.1099320","volume":"305","author":"Green D.R.","year":"2004","unstructured":"Green D.R.; Kroemer G.; The pathophysiology of mitochondrial cell death. Science 2004,305(5684),626-629","journal-title":"Science"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ceca.2018.07.001","volume":"74","author":"Wegierski T.","year":"2018","unstructured":"Wegierski T.; Kuznicki J.; Neuronal calcium signaling via store-operated channels in health and disease. Cell Calcium 2018,74,102-111","journal-title":"Cell Calcium"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.neuint.2016.07.003","volume":"99","author":"Singh A.","year":"2016","unstructured":"Singh A.; Verma P.; Balaji G.; Samantaray S.; Mohanakumar K.P.; Nimodipine, an L-type calcium channel blocker attenuates mitochondrial dysfunctions to protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice. Neurochem Int 2016,99,221-232","journal-title":"Neurochem Int"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1021\/acschemneuro.6b00181","volume":"8","author":"Buendia I.","year":"2017","unstructured":"Buendia I.; Tenti G.; Michalska P.; M\u00e9ndez-L\u00f3pez I.; Luengo E.; Satriani M.; Pad\u00edn-Nogueira F.; L\u00f3pez M.G.; Ramos M.T.; Garc\u00eda A.G.; Men\u00e9ndez J.C.; Le\u00f3n R.; ITH14001, a CGP37157-nimodipine hybrid designed to regulate calcium homeostasis and oxidative stress, exerts neuroprotection in cerebral ischemia. ACS Chem Neurosci 2017,8(1),67-81","journal-title":"ACS Chem Neurosci"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.bbr.2016.07.049","volume":"315","author":"Shen A.N.","year":"2016","unstructured":"Shen A.N.; Cummings C.; Hoffman D.; Pope D.; Arnold M.; Newland M.C.; Aging, motor function, and sensitivity to calcium channel blockers: an investigation using chronic methylmercury exposure. Behav Brain Res 2016,315,103-114","journal-title":"Behav Brain Res"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1212\/WNL.42.2.447","volume":"42","author":"McGeer P.L.","year":"1992","unstructured":"McGeer P.L.; Rogers J.; Anti-inflammatory agents as a therapeutic approach to Alzheimer\u2019s disease. Neurology 1992,42(2),447-449","journal-title":"Neurology"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1080\/21505594.2016.1261789","volume":"8","author":"Koutsouras G.W.","year":"2017","unstructured":"Koutsouras G.W.; Ramos R.L.; Martinez L.R.; Role of microglia in fungal infections of the central nervous system. Virulence 2017,8(6),705-718","journal-title":"Virulence"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"981","DOI":"10.5692\/clinicalneurol.54.981","volume":"54","author":"Yamasaki R.","year":"2014","unstructured":"Yamasaki R.; [Role of microglia in inflammatory demyelination lesion in the central nervous system Rinsho Shinkeigaku 2014,54(12),981-983","journal-title":"Rinsho Shinkeigaku"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1126\/science.1074069","volume":"298","author":"Selkoe D.J.","year":"2002","unstructured":"Selkoe D.J.; Alzheimer\u2019s disease is a synaptic failure. Science 2002,298(5594),789-791","journal-title":"Science"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1002\/jnr.22679","volume":"89","author":"Fuentealba J.","year":"2011","unstructured":"Fuentealba J.; Dibarrart A.J.; Fuentes-Fuentes M.C.; Saez-Orellana F.; Qui\u00f1ones K.; Guzm\u00e1n L.; Perez C.; Becerra J.; Aguayo L.G.; Synaptic failure and adenosine triphosphate imbalance induced by amyloid-\u03b2 aggregates are prevented by blueberry-enriched polyphenols extract. J Neurosci Res 2011,89(9),1499-1508","journal-title":"J Neurosci Res"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1515\/REVNEURO.2009.20.1.1","volume":"20","author":"Nimmrich V.","year":"2009","unstructured":"Nimmrich V.; Ebert U.; Is Alzheimer\u2019s disease a result of presynaptic failure? Synaptic dysfunctions induced by oligomeric beta-amyloid. Rev Neurosci 2009,20(1),1-12","journal-title":"Rev Neurosci"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/mds.26479","volume":"31","author":"Calo L.","year":"2016","unstructured":"Calo L.; Wegrzynowicz M.; Santiva\u00f1ez-Perez J.; Grazia Spillantini M.; Synaptic failure and \u03b1-synuclein. Mov Disord 2016,31(2),169-177","journal-title":"Mov Disord"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1074\/jbc.M109.030023","volume":"285","author":"Parodi J.","year":"2010","unstructured":"Parodi J.; Sep\u00falveda F.J.; Roa J.; Opazo C.; Inestrosa N.C.; Aguayo L.G.; Beta-amyloid causes depletion of synaptic vesicles leading to neurotransmission failure. J Biol Chem 2010,285(4),2506-2514","journal-title":"J Biol Chem"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/nan.12297","volume":"42","author":"Bellucci A.","year":"2016","unstructured":"Bellucci A.; Mercuri N.B.; Venneri A.; Faustini G.; Longhena F.; Pizzi M.; Missale C.; Spano P.; Review: Parkinson\u2019s disease: from synaptic loss to connectome dysfunction. Neuropathol Appl Neurobiol 2016,42(1),77-94","journal-title":"Neuropathol Appl Neurobiol"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/978-3-7091-0932-8_24","volume":"970","author":"Picconi B.","year":"2012","unstructured":"Picconi B.; Piccoli G.; Calabresi P.; Synaptic dysfunction in Parkinson\u2019s disease. Adv Exp Med Biol 2012,970,553-572","journal-title":"Adv Exp Med Biol"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1042\/BST0380493","volume":"38","author":"Bagetta V.","year":"2010","unstructured":"Bagetta V.; Ghiglieri V.; Sgobio C.; Calabresi P.; Picconi B.; Synaptic dysfunction in Parkinson\u2019s disease. Biochem Soc Trans 2010,38(2),493-497","journal-title":"Biochem Soc Trans"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.drudis.2014.02.006","volume":"19","author":"Sepers M.D.","year":"2014","unstructured":"Sepers M.D.; Raymond L.A.; Mechanisms of synaptic dysfunction and excitotoxicity in Huntington\u2019s disease. Drug Discov Today 2014,19(7),990-996","journal-title":"Drug Discov Today"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/j.1582-4934.2006.tb00439.x","volume":"10","author":"Forero D.A.","year":"2006","unstructured":"Forero D.A.; Casadesus G.; Perry G.; Arboleda H.; Synaptic dysfunction and oxidative stress in Alzheimer\u2019s disease: emerging mechanisms. J Cell Mol Med 2006,10(3),796-805","journal-title":"J Cell Mol Med"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1212\/WNL.0000000000005807","volume":"91","author":"Benarroch E.E.","year":"2018","unstructured":"Benarroch E.E.; Glutamatergic synaptic plasticity and dysfunction in Alzheimer disease: emerging mechanisms. Neurology 2018,91(3),125-132","journal-title":"Neurology"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fncel.2017.00053","volume":"11","author":"Criscuolo C.","year":"2017","unstructured":"Criscuolo C.; Fabiani C.; Cerri E.; Domenici L.; Synaptic dysfunction in Alzheimer\u2019s Disease and glaucoma: from common degenerative mechanisms toward neuroprotection. Front Cell Neurosci 2017,11,53","journal-title":"Front Cell Neurosci"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1042\/BST0351219","volume":"35","author":"Rowan M.J.","year":"2007","unstructured":"Rowan M.J.; Klyubin I.; Wang Q.; Hu N.W.; Anwyl R.; Synaptic memory mechanisms: Alzheimer\u2019s disease amyloid beta-peptide-induced dysfunction. Biochem Soc Trans 2007,35(Pt 5),1219-1223","journal-title":"Biochem Soc Trans"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1002\/dvdy.22292","volume":"239","author":"Kirstein-Miles J.","year":"2010","unstructured":"Kirstein-Miles J.; Morimoto R.I.; Caenorhabditis elegans as a model system to study intercompartmental proteostasis: Interrelation of mitochondrial function, longevity, and neurodegenerative diseases. Dev Dyn 2010,239(5),1529-1538","journal-title":"Dev Dyn"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1093\/jnen\/nlw002","volume":"75","author":"Elobeid A.","year":"2016","unstructured":"Elobeid A.; Libard S.; Leino M.; Popova S.N.; Alafuzoff I.; Altered Proteins in the Aging Brain. J Neuropathol Exp Neurol 2016,75(4),316-325","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3389\/fphar.2018.00145","volume":"9","author":"de Souza J.M.","year":"2018","unstructured":"de Souza J.M.; Goncalves B.D.C.; Gomez M.V.; Vieira L.B.; Ribeiro F.M.; Animal toxins as therapeutic tools to treat neurodegenerative diseases. Front Pharmacol 2018,9,145","journal-title":"Front Pharmacol"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/BF02185763","volume":"97","author":"Herskind A.M.","year":"1996","unstructured":"Herskind A.M.; McGue M.; Holm N.V.; S\u00f8rensen T.I.; Harvald B.; Vaupel J.W.; The heritability of human longevity: a population-based study of 2872 Danish twin pairs born 1870-1900. Hum Genet 1996,97(3),319-323","journal-title":"Hum Genet"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1089\/ars.2009.2598","volume":"12","author":"Terman A.","year":"2010","unstructured":"Terman A.; Kurz T.; Navratil M.; Arriaga E.A.; Brunk U.T.; Mitochondrial turnover and aging of long-lived postmitotic cells: the mitochondrial-lysosomal axis theory of aging. Antioxid Redox Signal 2010,12(4),503-535","journal-title":"Antioxid Redox Signal"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1046\/j.1432-1033.2002.02869.x","volume":"269","author":"Brunk U.T.","year":"2002","unstructured":"Brunk U.T.; Terman A.; The mitochondrial-lysosomal axis theory of aging: accumulation of damaged mitochondria as a result of imperfect autophagocytosis. Eur J Biochem 2002,269(8),1996-2002","journal-title":"Eur J Biochem"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1093\/hmg\/ddq561","volume":"20","author":"Hernandez D.G.","year":"2011","unstructured":"Hernandez D.G.; Nalls M.A.; Gibbs J.R.; Arepalli S.; van der Brug M.; Chong S.; Moore M.; Longo D.L.; Cookson M.R.; Traynor B.J.; Singleton A.B.; Distinct DNA methylation changes highly correlated with chronological age in the human brain. Hum Mol Genet 2011,20(6),1164-1172","journal-title":"Hum Mol Genet"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1111\/acel.12362","volume":"14","author":"Johnson S.C.","year":"2015","unstructured":"Johnson S.C.; Dong X.; Vijg J.; Suh Y.; Genetic evidence for common pathways in human age-related diseases. Aging Cell 2015,14(5),809-817","journal-title":"Aging Cell"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"16848","DOI":"10.3390\/ijms150916848","volume":"15","author":"Jenwitheesuk A.","year":"2014","unstructured":"Jenwitheesuk A.; Nopparat C.; Mukda S.; Wongchitrat P.; Govitrapong P.; Melatonin regulates aging and neurodegeneration through energy metabolism, epigenetics, autophagy and circadian rhythm pathways. Int J Mol Sci 2014,15(9),16848-16884","journal-title":"Int J Mol Sci"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.mad.2006.01.022","volume":"127","author":"Lee S.T.","year":"2006","unstructured":"Lee S.T.; Kim M.; Aging and neurodegeneration. Molecular mechanisms of neuronal loss in Huntington\u2019s disease. Mech Ageing Dev 2006,127(5),432-435","journal-title":"Mech Ageing Dev"},{"key":"ref=121","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a025130","volume":"5","author":"Maynard S.","year":"2015","unstructured":"Maynard S.; Fang E.F.; Scheibye-Knudsen M.; Croteau D.L.; Bohr V.A.; DNA damage, DNA repair, aging, and neurodegeneration. Cold Spring Harb Perspect Med 2015,5(10)","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1073\/pnas.1400954111","volume":"111","author":"Porder S.","year":"2014","unstructured":"Porder S.; Coevolution of life and landscapes. Proc Natl Acad Sci USA 2014,111(9),3207-3208","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1126\/science.1200486","volume":"332","author":"Lazzaro B.P.","year":"2011","unstructured":"Lazzaro B.P.; Rolff, J. Immunology. Danger, microbes, and homeostasis. Science 2011,332(6025),43-44","journal-title":"Science"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/nature01767","volume":"424","author":"Yoshida T.","year":"2003","unstructured":"Yoshida T.; Jones L.E.; Ellner S.P.; Fussmann G.F.; Hairston N.G.; Rapid evolution drives ecological dynamics in a predator-prey system. Nature 2003,424(6946),303-306","journal-title":"Nature"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1749-6632.1975.tb26833.x","volume":"245","author":"Russell F.E.","year":"1975","unstructured":"Russell F.E.; Poisonous and venomous marine animals and their toxins. Ann N Y Acad Sci 1975,245,57-64","journal-title":"Ann N Y Acad Sci"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ceb.2013.12.002","volume":"27","author":"Bradley S.J.","year":"2014","unstructured":"Bradley S.J.; Riaz S.A.; Tobin A.B.; Employing novel animal models in the design of clinically efficacious GPCR ligands. Curr Opin Cell Biol 2014,27,117-125","journal-title":"Curr Opin Cell Biol"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"661","DOI":"10.4155\/fmc.12.4","volume":"4","author":"Wickenden A.","year":"2012","unstructured":"Wickenden A.; Priest B.; Erdemli G.; Ion channel drug discovery: challenges and future directions. Future Med Chem 2012,4(5),661-679","journal-title":"Future Med Chem"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/nrd4052","volume":"12","author":"Wootten D.","year":"2013","unstructured":"Wootten D.; Christopoulos A.; Sexton P.M.; Emerging paradigms in GPCR allostery: implications for drug discovery. Nat Rev Drug Discov 2013,12(8),630-644","journal-title":"Nat Rev Drug Discov"},{"key":"ref=129","first-page":"183","volume":"36","author":"Zhang Y.","year":"2015","unstructured":"Zhang Y.; Why do we study animal toxins? Zool Res 2015,36(4),183-222","journal-title":"Zool Res"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.tree.2012.10.020","volume":"28","author":"Casewell N.R.","year":"2013","unstructured":"Casewell N.R.; W\u00fcster W.; Vonk F.J.; Harrison R.A.; Fry B.G.; Complex cocktails: the evolutionary novelty of venoms. Trends Ecol Evol (Amst) 2013,28(4),219-229","journal-title":"Trends Ecol Evol (Amst)"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1146\/annurev.genom.9.081307.164356","volume":"10","author":"Fry B.G.","year":"2009","unstructured":"Fry B.G.; Roelants K.; Champagne D.E.; Scheib H.; Tyndall J.D.; King G.F.; Nevalainen T.J.; Norman J.A.; Lewis R.J.; Norton R.S.; Renjifo C.; de la Vega R.C.; The toxicogenomic multiverse: convergent recruitment of proteins into animal venoms. Annu Rev Genomics Hum Genet 2009,10,483-511","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.toxicon.2006.02.005","volume":"47","author":"Haddad V.","year":"2006","unstructured":"Haddad V.; Martins I.A.; Frequency and gravity of human envenomations caused by marine catfish (suborder siluroidei): a clinical and epidemiological study. Toxicon 2006,47(8),838-843","journal-title":"Toxicon"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s00134-018-5226-5","volume":"45","author":"Abroug F.","year":"2019","unstructured":"Abroug F.; Ouanes-Besbes L.; Bouchoucha S.; Scorpion envenomation: from a neglected to a helpful disease? Intensive Care Med 2019,45(1),72-74","journal-title":"Intensive Care Med"},{"key":"ref=134","first-page":"1558","volume":"371","author":"Comellas A.P.","year":"2014","unstructured":"Comellas A.P.; Pesce L.M.; Scorpion envenomation. N Engl J Med 2014,371(16),1558","journal-title":"N Engl J Med"},{"key":"ref=135","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050221","volume":"5","author":"Chippaux J.P.","year":"2008","unstructured":"Chippaux J.P.; Estimating the global burden of snakebite can help to improve management. PLoS Med 2008,5(11)","journal-title":"PLoS Med"},{"key":"ref=136","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050218","volume":"5","author":"Kasturiratne A.","year":"2008","unstructured":"Kasturiratne A.; Wickremasinghe A.R.; de Silva N.; Gunawardena N.K.; Pathmeswaran A.; Premaratna R.; Savioli L.; Lalloo D.G.; de Silva H.J.; The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths. PLoS Med 2008,5(11)","journal-title":"PLoS Med"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1073\/pnas.42.9.571","volume":"42","author":"Cohen S.","year":"1956","unstructured":"Cohen S.; Levi-Montalcini R.; A nerve growth-stimulating factor isolated from snake venom. Proc Natl Acad Sci USA 1956,42(9),571-574","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1152\/ajplegacy.1949.156.2.261","volume":"156","author":"Rocha e Silva M.","year":"1949","unstructured":"Rocha e Silva M.; Beraldo W.T.; Rosenfeld G.; Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and by trypsin. Am J Physiol 1949,156(2),261-273","journal-title":"Am J Physiol"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"13315","DOI":"10.1074\/jbc.R109.076596","volume":"285","author":"Dutertre S.","year":"2010","unstructured":"Dutertre S.; Lewis R.J.; Use of venom peptides to probe ion channel structure and function. J Biol Chem 2010,285(18),13315-13320","journal-title":"J Biol Chem"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"2e00594","DOI":"10.7554\/eLife.00594","author":"Banerjee A.","year":"2013","unstructured":"Banerjee A.; Lee A.; Campbell E.; Mackinnon R.; Structure of a pore-blocking toxin in complex with a eukaryotic voltagedependent K(+) channel. eLife 2013,2e00594"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/350232a0","volume":"350","author":"MacKinnon R.","year":"1991","unstructured":"MacKinnon R.; Determination of the subunit stoichiometry of a voltage-activated potassium channel. Nature 1991,350(6315),232-235","journal-title":"Nature"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1126\/science.7716527","volume":"268","author":"Hidalgo P.","year":"1995","unstructured":"Hidalgo P.; MacKinnon R.; Revealing the architecture of a K+ channel pore through mutant cycles with a peptide inhibitor. Science 1995,268(5208),307-310","journal-title":"Science"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/S0014-5793(03)01104-9","volume":"555","author":"MacKinnon R.","year":"2003","unstructured":"MacKinnon R.; Potassium channels. FEBS Lett 2003,555(1),62-65","journal-title":"FEBS Lett"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.pharmthera.2010.08.006","volume":"128","author":"Deval E.","year":"2010","unstructured":"Deval E.; Gasull X.; No\u00ebl J.; Salinas M.; Baron A.; Diochot S.; Lingueglia E.; Acid-sensing ion channels (ASICs): pharmacology and implication in pain. Pharmacol Ther 2010,128(3),549-558","journal-title":"Pharmacol Ther"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.toxicon.2013.04.008","volume":"75","author":"Baron A.","year":"2013","unstructured":"Baron A.; Diochot S.; Salinas M.; Deval E.; Noel J.; Lingueglia E.; Venom toxins in the exploration of molecular, physiological and pathophysiological functions of acid-sensing ion channels. Toxicon 2013,75,187-204","journal-title":"Toxicon"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/nature10607","volume":"479","author":"Bohlen C.J.","year":"2011","unstructured":"Bohlen C.J.; Chesler A.T.; Sharif-Naeini R.; Medzihradszky K.F.; Zhou S.; King D.; S\u00e1nchez E.E.; Burlingame A.L.; Basbaum A.I.; Julius D.; A heteromeric Texas coral snake toxin targets acid-sensing ion channels to produce pain. Nature 2011,479(7373),410-414","journal-title":"Nature"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.cell.2014.01.011","volume":"156","author":"Baconguis I.","year":"2014","unstructured":"Baconguis I.; Bohlen C.J.; Goehring A.; Julius D.; Gouaux E.; X-ray structure of acid-sensing ion channel 1-snake toxin complex reveals open state of a Na(+)-selective channel. Cell 2014,156(4),717-729","journal-title":"Cell"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nature11494","volume":"490","author":"Diochot S.","year":"2012","unstructured":"Diochot S.; Baron A.; Salinas M.; Douguet D.; Scarzello S.; Dabert-Gay A.S.; Debayle D.; Friend V.; Alloui A.; Lazdunski M.; Lingueglia E.; Black mamba venom peptides target acid-sensing ion channels to abolish pain. Nature 2012,490(7421),552-555","journal-title":"Nature"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"8153","DOI":"10.1039\/C5CC01418B","volume":"51","author":"Wen M.","year":"2015","unstructured":"Wen M.; Guo X.; Sun P.; Xiao L.; Li J.; Xiong Y.; Bao J.; Xue T.; Zhang L.; Tian C.; Site-specific fluorescence spectrum detection and characterization of hASIC1a channels upon toxin mambalgin-1 binding in live mammalian cells. Chem Commun (Camb) 2015,51(38),8153-8156","journal-title":"Chem Commun (Camb)"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/anie.201308898","volume":"53","author":"Schroeder C.I.","year":"2014","unstructured":"Schroeder C.I.; Rash L.D.; Vila-Farr\u00e9s X.; Rosengren K.J.; Mobli M.; King G.F.; Alewood P.F.; Craik D.J.; Durek T.; Chemical synthesis, 3D structure, and ASIC binding site of the toxin mambalgin-2. Angew Chem Int Ed Engl 2014,53(4),1017-1020","journal-title":"Angew Chem Int Ed Engl"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"13363","DOI":"10.1074\/jbc.M114.561076","volume":"289","author":"Salinas M.","year":"2014","unstructured":"Salinas M.; Besson T.; Delettre Q.; Diochot S.; Boulakirba S.; Douguet D.; Lingueglia E.; Binding site and inhibitory mechanism of the mambalgin-2 pain-relieving peptide on acid-sensing ion channel 1a. J Biol Chem 2014,289(19),13363-13373","journal-title":"J Biol Chem"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.toxicon.2012.09.003","volume":"62","author":"Serrano S.M.","year":"2013","unstructured":"Serrano S.M.; The long road of research on snake venom serine proteinases. Toxicon 2013,62,19-26","journal-title":"Toxicon"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/S0969-2126(98)00119-1","volume":"6","author":"Parry M.A.","year":"1998","unstructured":"Parry M.A.; Jacob U.; Huber R.; Wisner A.; Bon C.; Bode W.; The crystal structure of the novel snake venom plasminogen activator TSV-PA: a prototype structure for snake venom serine proteinases. Structure 1998,6(9),1195-1206","journal-title":"Structure"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1111\/j.1538-7836.2010.03875.x","volume":"8","author":"Watson S.P.","year":"2010","unstructured":"Watson S.P.; Herbert J.M.; Pollitt A.Y.; GPVI and CLEC-2 in hemostasis and vascular integrity. J Thromb Haemost 2010,8(7),1456-1467","journal-title":"J Thromb Haemost"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/0041-0101(81)90085-4","volume":"19","author":"Prado-Franceschi J.","year":"1981","unstructured":"Prado-Franceschi J.; Brazil O.V.; Convulxin, a new toxin from the venom of the South American rattlesnake Crotalus durissus terrificus. Toxicon 1981,19(6),875-887","journal-title":"Toxicon"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"29019","DOI":"10.1074\/jbc.274.41.29019","volume":"274","author":"Clemetson J.M.","year":"1999","unstructured":"Clemetson J.M.; Polgar J.; Magnenat E.; Wells T.N.; Clemetson K.J.; The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcalphaR and the natural killer receptors. J Biol Chem 1999,274(41),29019-29024","journal-title":"J Biol Chem"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1084\/jem.20141505","volume":"212","author":"Bourgeois E.A.","year":"2015","unstructured":"Bourgeois E.A.; Subramaniam S.; Cheng T.Y.; De Jong A.; Layre E.; Ly D.; Salimi M.; Legaspi A.; Modlin R.L.; Salio M.; Cerundolo V.; Moody D.B.; Ogg G.; Bee venom processes human skin lipids for presentation by CD1a. J Exp Med 2015,212(2),149-163","journal-title":"J Exp Med"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nature11047","volume":"484","author":"Palm N.W.","year":"2012","unstructured":"Palm N.W.; Rosenstein R.K.; Medzhitov R.; Allergic host defences. Nature 2012,484(7395),465-472","journal-title":"Nature"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.immuni.2013.10.006","volume":"39","author":"Palm N.W.","year":"2013","unstructured":"Palm N.W.; Rosenstein R.K.; Yu S.; Schenten D.D.; Florsheim E.; Medzhitov R.; Bee venom phospholipase A2 induces a primary type 2 response that is dependent on the receptor ST2 and confers protective immunity. Immunity 2013,39(5),976-985","journal-title":"Immunity"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.immuni.2013.10.005","volume":"39","author":"Marichal T.","year":"2013","unstructured":"Marichal T.; Starkl P.; Reber L.L.; Kalesnikoff J.; Oettgen H.C.; Tsai M.; Metz M.; Galli S.J.; A beneficial role for immunoglobulin E in host defense against honeybee venom. Immunity 2013,39(5),963-975","journal-title":"Immunity"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1746-4269-7-12","volume":"7","author":"Machkour-M\u2019Rabet S.","year":"2011","unstructured":"Machkour-M\u2019Rabet S.; H\u00e9naut Y.; Winterton P.; Rojo R.; A case of zootherapy with the tarantula Brachypelma vagans Ausserer, 1875 in traditional medicine of the Chol Mayan ethnic group in Mexico. J Ethnobiol Ethnomed 2011,7,12","journal-title":"J Ethnobiol Ethnomed"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1615\/CritRevImmunol.v27.i4.10","volume":"27","author":"Reid P.F.","year":"2007","unstructured":"Reid P.F.; Alpha-cobratoxin as a possible therapy for multiple sclerosis: a review of the literature leading to its development for this application. Crit Rev Immunol 2007,27(4),291-302","journal-title":"Crit Rev Immunol"},{"key":"ref=163","first-page":"58","volume":"17","author":"Reid P.F.","year":"2011","unstructured":"Reid P.F.; Cobra venom: A review of the old alternative to opiate analgesics. Altern Ther Health Med 2011,17(1),58-71","journal-title":"Altern Ther Health Med"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.pain.2008.03.012","volume":"137","author":"Michalsen A.","year":"2008","unstructured":"Michalsen A.; L\u00fcdtke R.; Cesur O.; Afra D.; Musial F.; Baecker M.; Fink M.; Dobos G.J.; Effectiveness of leech therapy in women with symptomatic arthrosis of the first carpometacarpal joint: a randomized controlled trial. Pain 2008,137(2),452-459","journal-title":"Pain"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4103\/2152-7806.105098","volume":"3","author":"Nouri M.","year":"2012","unstructured":"Nouri M.; Karimi-Yarandi K.; Etezadi F.; Amirjamshidi A.; Leech therapy for pain relief: rational behind a notion. Surg Neurol Int 2012,3,159","journal-title":"Surg Neurol Int"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"5309","DOI":"10.1002\/cncr.24602","volume":"115","author":"Meng Z.","year":"2009","unstructured":"Meng Z.; Yang P.; Shen Y.; Bei W.; Zhang Y.; Ge Y.; Newman R.A.; Cohen L.; Liu L.; Thornton B.; Chang D.Z.; Liao Z.; Kurzrock R.; Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer. Cancer 2009,115(22),5309-5318","journal-title":"Cancer"},{"key":"ref=167","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113272","volume":"9","author":"Wang Z.J.","year":"2014","unstructured":"Wang Z.J.; Sun L.; Heinbockel T.; Resibufogenin and cinobufagin activate central neurons through an ouabain-like action. PLoS One 2014,9(11)","journal-title":"PLoS One"},{"key":"ref=168","doi-asserted-by":"publisher","DOI":"10.3390\/toxins10030126","volume":"10","author":"Peigneur S.","year":"2018","unstructured":"Peigneur S.; Tytgat J.; Toxins in drug discovery and pharmacology. Toxins (Basel) 2018,10(3)","journal-title":"Toxins (Basel)"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.toxicon.2014.10.020","volume":"92","author":"Harvey A.L.","year":"2014","unstructured":"Harvey A.L.; Toxins and drug discovery. Toxicon 2014,92,193-200","journal-title":"Toxicon"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.coph.2008.11.007","volume":"9","author":"Hodgson W.C.","year":"2009","unstructured":"Hodgson W.C.; Isbister G.K.; The application of toxins and venoms to cardiovascular drug discovery. Curr Opin Pharmacol 2009,9(2),173-176","journal-title":"Curr Opin Pharmacol"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1517\/14712598.2011.621940","volume":"11","author":"King G.F.","year":"2011","unstructured":"King G.F.; Venoms as a platform for human drugs: translating toxins into therapeutics. Expert Opin Biol Ther 2011,11(11),1469-1484","journal-title":"Expert Opin Biol Ther"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1161\/01.HYP.17.4.589","volume":"17","author":"Cushman D.W.","year":"1991","unstructured":"Cushman D.W.; Ondetti M.A.; History of the design of captopril and related inhibitors of angiotensin converting enzyme. Hypertension 1991,17(4),589-592","journal-title":"Hypertension"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.toxicon.2012.09.008","volume":"62","author":"McCleary R.J.","year":"2013","unstructured":"McCleary R.J.; Kini R.M.; Non-enzymatic proteins from snake venoms: a gold mine of pharmacological tools and drug leads. Toxicon 2013,62,56-74","journal-title":"Toxicon"},{"key":"ref=174","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0021-9258(18)54042-4","volume":"268","author":"Scarborough R.M.","year":"1993","unstructured":"Scarborough R.M.; Naughton M.A.; Teng W.; Rose J.W.; Phillips D.R.; Nannizzi L.; Arfsten A.; Campbell A.M.; Charo I.F.; Design of potent and specific integrin antagonists. Peptide antagonists with high specificity for glycoprotein IIb-IIIa. J Biol Chem 1993,268(2),1066-1073","journal-title":"J Biol Chem"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/S0002-8703(99)70075-X","volume":"138","author":"Scarborough R.M.","year":"1999","unstructured":"Scarborough R.M.; Development of eptifibatide. Am Heart J 1999,138(6 Pt 1),1093-1104","journal-title":"Am Heart J"},{"key":"ref=176","doi-asserted-by":"crossref","first-page":"9359","DOI":"10.1016\/S0021-9258(18)92826-7","volume":"266","author":"Scarborough R.M.","year":"1991","unstructured":"Scarborough R.M.; Rose J.W.; Hsu M.A.; Phillips D.R.; Fried V.A.; Campbell A.M.; Nannizzi L.; Charo I.F.; Barbourin. A GPIIb-IIIa-specific integrin antagonist from the venom of Sistrurus m. barbouri. J Biol Chem 1991,266(15),9359-9362","journal-title":"J Biol Chem"},{"key":"ref=177","first-page":"20","volume":"272","author":"Lynch J.J.","year":"1995","unstructured":"Lynch J.J.; Cook J.J.; Sitko G.R.; Holahan M.A.; Ramjit D.R.; Mellott M.J.; Stranieri M.T.; Stabilito I.I.; Zhang G.; Lynch R.J.; Nonpeptide glycoprotein IIb\/IIIa inhibitors. 5. Antithrombotic effects of MK-0383. J Pharmacol Exp Ther 1995,272(1),20-32","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"7369","DOI":"10.1021\/bi00244a003","volume":"30","author":"Saudek V.","year":"1991","unstructured":"Saudek V.; Atkinson R.A.; Pelton J.T.; Three-dimensional structure of echistatin, the smallest active RGD protein. Biochemistry 1991,30(30),7369-7372","journal-title":"Biochemistry"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1016\/S0960-894X(99)00308-X","volume":"9","author":"Xu T.L.","year":"1999","unstructured":"Xu T.L.; Jiang X.T.; Hua W.Y.; Ni P.Z.; Pei Y.M.; Design and synthesis of amidino-tyrosine derivatives as non-peptide fibrinogen receptor antagonists. Bioorg Med Chem Lett 1999,9(14),1933-1936","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1021\/jm00042a007","volume":"37","author":"Egbertson M.S.","year":"1994","unstructured":"Egbertson M.S.; Chang C.T.; Duggan M.E.; Gould R.J.; Halczenko W.; Hartman G.D.; Laswell W.L.; Lynch J.J.; Lynch R.J.; Manno P.D.; Non-peptide fibrinogen receptor antagonists. 2. Optimization of a tyrosine template as a mimic for Arg-Gly-Asp. J Med Chem 1994,37(16),2537-2551","journal-title":"J Med Chem"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"7095","DOI":"10.1021\/bi00482a021","volume":"29","author":"Maraganore J.M.","year":"1990","unstructured":"Maraganore J.M.; Bourdon P.; Jablonski J.; Ramachandran K.L.; Fenton J.W.; Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin. Biochemistry 1990,29(30),7095-7101","journal-title":"Biochemistry"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1161\/CIRCRESAHA.112.264903","volume":"111","author":"Coppens M.","year":"2012","unstructured":"Coppens M.; Eikelboom J.W.; Gustafsson D.; Weitz J.I.; Hirsh J.; Translational success stories: development of direct thrombin inhibitors. Circ Res 2012,111(7),920-929","journal-title":"Circ Res"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1126\/science.4071055","volume":"230","author":"Olivera B.M.","year":"1985","unstructured":"Olivera B.M.; Gray W.R.; Zeikus R.; McIntosh J.M.; Varga J.; Rivier J.; de Santos V.; Cruz L.J.; Peptide neurotoxins from fish-hunting cone snails. Science 1985,230(4732),1338-1343","journal-title":"Science"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1517\/14656566.2013.784269","volume":"14","author":"Pope J.E.","year":"2013","unstructured":"Pope J.E.; Deer T.R.; Ziconotide: a clinical update and pharmacologic review. Expert Opin Pharmacother 2013,14(7),957-966","journal-title":"Expert Opin Pharmacother"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ygcen.2011.11.025","volume":"175","author":"Irwin D.M.","year":"2012","unstructured":"Irwin D.M.; Origin and convergent evolution of exendin genes. Gen Comp Endocrinol 2012,175(1),27-33","journal-title":"Gen Comp Endocrinol"},{"key":"ref=186","doi-asserted-by":"crossref","first-page":"7402","DOI":"10.1016\/S0021-9258(18)42531-8","volume":"267","author":"Eng J.","year":"1992","unstructured":"Eng J.; Kleinman W.A.; Singh L.; Singh G.; Raufman J.P.; Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. J Biol Chem 1992,267(11),7402-7405","journal-title":"J Biol Chem"},{"key":"ref=187","doi-asserted-by":"crossref","first-page":"19650","DOI":"10.1016\/S0021-9258(19)36565-2","volume":"268","author":"G\u00f6ke R.","year":"1993","unstructured":"G\u00f6ke R.; Fehmann H.C.; Linn T.; Schmidt H.; Krause M.; Eng J.; G\u00f6ke B.; Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells. J Biol Chem 1993,268(26),19650-19655","journal-title":"J Biol Chem"},{"key":"ref=188","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3233\/JPD-140364","volume":"4","author":"Aviles-Olmos I.","year":"2014","unstructured":"Aviles-Olmos I.; Dickson J.; Kefalopoulou Z.; Djamshidian A.; Kahan J.; Ell P.; Whitton P.; Wyse R.; Isaacs T.; Lees A.; Limousin P.; Foltynie T.; Motor and cognitive advantages persist 12 months after exenatide exposure in Parkinson\u2019s disease. J Parkinsons Dis 2014,4(3),337-344","journal-title":"J Parkinsons Dis"},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1016\/j.jalz.2013.12.005","volume":"10","author":"Foltynie T.","year":"2014","unstructured":"Foltynie T.; Aviles-Olmos I.; Exenatide as a potential treatment for patients with Parkinson\u2019s disease: first steps into the clinic. Alzheimers Dement 2014,10(1)(Suppl.),S38-S46","journal-title":"Alzheimers Dement"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1517\/17460441.2013.741580","volume":"8","author":"Parkes D.G.","year":"2013","unstructured":"Parkes D.G.; Mace K.F.; Trautmann M.E.; Discovery and development of exenatide: the first antidiabetic agent to leverage the multiple benefits of the incretin hormone, GLP-1. Expert Opin Drug Discov 2013,8(2),219-244","journal-title":"Expert Opin Drug Discov"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2202-13-33","volume":"13","author":"Hunter K.","year":"2012","unstructured":"Hunter K.; H\u00f6lscher C.; Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis. BMC Neurosci 2012,13,33","journal-title":"BMC Neurosci"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/S0140-6736(17)31585-4","volume":"390","author":"Athauda D.","year":"2017","unstructured":"Athauda D.; Maclagan K.; Skene S.S.; Bajwa-Joseph M.; Letchford D.; Chowdhury K.; Hibbert S.; Budnik N.; Zampedri L.; Dickson J.; Li Y.; Aviles-Olmos I.; Warner T.T.; Limousin P.; Lees A.J.; Greig N.H.; Tebbs S.; Foltynie T.; Exenatide once weekly versus placebo in Parkinson\u2019s disease: a randomised, double-blind, placebo-controlled trial. Lancet 2017,390(10103),1664-1675","journal-title":"Lancet"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.drudis.2016.01.013","volume":"21","author":"Athauda D.","year":"2016","unstructured":"Athauda D.; Foltynie T.; The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson\u2019s disease: mechanisms of action. Drug Discov Today 2016,21(5),802-818","journal-title":"Drug Discov Today"},{"key":"ref=194","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/j.1463-1326.2010.01238.x","volume":"12","author":"Fan R.","year":"2010","unstructured":"Fan R.; Li X.; Gu X.; Chan J.C.; Xu G.; Exendin-4 protects pancreatic beta cells from human islet amyloid polypeptide-induced cell damage: potential involvement of AKT and mitochondria biogenesis. Diabetes Obes Metab 2010,12(9),815-824","journal-title":"Diabetes Obes Metab"},{"key":"ref=195","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S1474-4422(07)70327-7","volume":"7","author":"Schapira A.H.","year":"2008","unstructured":"Schapira A.H.; Mitochondria in the aetiology and pathogenesis of Parkinson\u2019s disease. Lancet Neurol 2008,7(1),97-109","journal-title":"Lancet Neurol"},{"key":"ref=196","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ejphar.2015.09.029","volume":"768","author":"Chen Y.","year":"2015","unstructured":"Chen Y.; Zhang Y.; Li L.; H\u00f6lscher C.; Neuroprotective effects of geniposide in the MPTP mouse model of Parkinson\u2019s disease. Eur J Pharmacol 2015,768,21-27","journal-title":"Eur J Pharmacol"},{"key":"ref=197","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1073\/pnas.0806720106","volume":"106","author":"Li Y.","year":"2009","unstructured":"Li Y.; Perry T.; Kindy M.S.; Harvey B.K.; Tweedie D.; Holloway H.W.; Powers K.; Shen H.; Egan J.M.; Sambamurti K.; Brossi A.; Lahiri D.K.; Mattson M.P.; Hoffer B.J.; Wang Y.; Greig N.H.; GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism. Proc Natl Acad Sci USA 2009,106(4),1285-1290","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=198","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1111\/j.1471-4159.2010.06731.x","volume":"113","author":"Li Y.","year":"2010","unstructured":"Li Y.; Tweedie D.; Mattson M.P.; Holloway H.W.; Greig N.H.; Enhancing the GLP-1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells. J Neurochem 2010,113(6),1621-1631","journal-title":"J Neurochem"},{"key":"ref=199","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.neuropharm.2017.09.040","volume":"128","author":"Xie Z.","year":"2018","unstructured":"Xie Z.; Enkhjargal B.; Wu L.; Zhou K.; Sun C.; Hu X.; Gospodarev V.; Tang J.; You C.; Zhang J.H.; Exendin-4 attenuates neuronal death via GLP-1R\/PI3K\/Akt pathway in early brain injury after subarachnoid hemorrhage in rats. Neuropharmacology 2018,128,142-151","journal-title":"Neuropharmacology"},{"key":"ref=200","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1124\/jpet.102.037481","volume":"302","author":"Perry T.","year":"2002","unstructured":"Perry T.; Haughey N.J.; Mattson M.P.; Egan J.M.; Greig N.H.; Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4. J Pharmacol Exp Ther 2002,302(3),881-888","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=201","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1093\/brain\/awx044","volume":"140","author":"Bassil F.","year":"2017","unstructured":"Bassil F.; Canron M.H.; Vital A.; Bezard E.; Li Y.; Greig N.H.; Gulyani S.; Kapogiannis D.; Fernagut P.O.; Meissner W.G.; Insulin resistance and exendin-4 treatment for multiple system atrophy. Brain 2017,140(5),1420-1436","journal-title":"Brain"},{"key":"ref=202","doi-asserted-by":"publisher","first-page":"R1785","DOI":"10.1152\/ajpregu.00519.2009","volume":"297","author":"Raab E.L.","year":"2009","unstructured":"Raab E.L.; Vuguin P.M.; Stoffers D.A.; Simmons R.A.; Neonatal exendin-4 treatment reduces oxidative stress and prevents hepatic insulin resistance in intrauterine growth-retarded rats. Am J Physiol Regul Integr Comp Physiol 2009,297(6),R1785-R1794","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref=203","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/JIM.0000000000000129","volume":"63","author":"Xu W.","year":"2015","unstructured":"Xu W.; Yang Y.; Yuan G.; Zhu W.; Ma D.; Hu S.; Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces Alzheimer disease-associated tau hyperphosphorylation in the hippocampus of rats with type 2 diabetes. J Investig Med 2015,63(2),267-272","journal-title":"J Investig Med"},{"key":"ref=204","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1677\/JOE-09-0132","volume":"202","author":"Kim S.","year":"2009","unstructured":"Kim S.; Moon M.; Park S.; Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson\u2019s disease. J Endocrinol 2009,202(3),431-439","journal-title":"J Endocrinol"},{"key":"ref=205","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1742-2094-5-19","volume":"5","author":"Harkavyi A.","year":"2008","unstructured":"Harkavyi A.; Abuirmeileh A.; Lever R.; Kingsbury A.E.; Biggs C.S.; Whitton P.S.; Glucagon-like peptide 1 receptor stimulation reverses key deficits in distinct rodent models of Parkinson\u2019s disease. J Neuroinflammation 2008,5,19","journal-title":"J Neuroinflammation"},{"key":"ref=206","doi-asserted-by":"publisher","first-page":"227","DOI":"10.5607\/en.2017.26.4.227","volume":"26","author":"Kim S.","year":"2017","unstructured":"Kim S.; Jeong J.; Jung H.S.; Kim B.; Kim Y.E.; Lim D.S.; Kim S.D.; Song Y.S.; Anti-inflammatory effect of glucagon like peptide-1 receptor agonist, exendin-4, through modulation of IB1\/JIP1 Expression and JNK signaling in stroke. Exp Neurobiol 2017,26(4),227-239","journal-title":"Exp Neurobiol"},{"key":"ref=207","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1177\/0963689717721234","volume":"26","author":"Kim D.S.","year":"2017","unstructured":"Kim D.S.; Choi H.I.; Wang Y.; Luo Y.; Hoffer B.J.; Greig N.H.; A new treatment strategy for Parkinson\u2019s Disease through the gut-brain axis: the glucagon-like peptide-1 receptor pathway. Cell Transplant 2017,26(9),1560-1571","journal-title":"Cell Transplant"},{"key":"ref=208","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.neuropharm.2017.09.023","volume":"136","author":"Athauda D.","year":"2018","unstructured":"Athauda D.; Foltynie T.; Protective effects of the GLP-1 mimetic exendin-4 in Parkinson\u2019s disease. Neuropharmacology, 2018,136(Pt B),260-270","journal-title":"Neuropharmacology,"},{"key":"ref=209","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.neuint.2005.12.023","volume":"48","author":"Zieminska E.","year":"2006","unstructured":"Zieminska E.; Matyja E.; Kozlowska H.; Stafiej A.; Lazarewicz J.W.; Excitotoxic neuronal injury in acute homocysteine neurotoxicity: role of calcium and mitochondrial alterations. Neurochem Int 2006,48(6-7),491-497","journal-title":"Neurochem Int"},{"key":"ref=210","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/j.1749-6632.1994.tb44407.x","volume":"747","author":"Choi D.W.","year":"1994","unstructured":"Choi D.W.; Calcium and excitotoxic neuronal injury. Ann N Y Acad Sci 1994,747,162-171","journal-title":"Ann N Y Acad Sci"},{"key":"ref=211","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1126\/science.7832825","volume":"264","author":"Wheeler D.B.","year":"1994","unstructured":"Wheeler D.B.; Randall A.; Tsien R.W.; Roles of N-type and Q-type Ca2+ channels in supporting hippocampal synaptic transmission. Science 1994,264(5155),107-111","journal-title":"Science"},{"key":"ref=212","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/0166-2236(95)80018-W","volume":"18","author":"Choi D.W.","year":"1995","unstructured":"Choi D.W.; Calcium: still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci 1995,18(2),58-60","journal-title":"Trends Neurosci"},{"key":"ref=213","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/S0041-0101(96)00210-3","volume":"35","author":"Uchitel O.D.","year":"1997","unstructured":"Uchitel O.D.; Toxins affecting calcium channels in neurons. Toxicon 1997,35(8),1161-1191","journal-title":"Toxicon"},{"key":"ref=214","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1161\/01.STR.27.11.2124","volume":"27","author":"Pringle A.K.","year":"1996","unstructured":"Pringle A.K.; Benham C.D.; Sim L.; Kennedy J.; Iannotti F.; Sundstrom L.E.; Selective N-type calcium channel antagonist omega conotoxin MVIIA is neuroprotective against hypoxic neurodegeneration in organotypic hippocampal-slice cultures. Stroke 1996,27(11),2124-2130","journal-title":"Stroke"},{"key":"ref=215","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1021\/bi00382a004","volume":"26","author":"Olivera B.M.","year":"1987","unstructured":"Olivera B.M.; Cruz L.J.; de Santos V.; LeCheminant G.W.; Griffin D.; Zeikus R.; McIntosh J.M.; Galyean R.; Varga J.; Gray W.R.; Neuronal calcium channel antagonists. Discrimination between calcium channel subtypes using omega-conotoxin from Conus magus venom. Biochemistry 1987,26(8),2086-2090","journal-title":"Biochemistry"},{"key":"ref=216","doi-asserted-by":"publisher","first-page":"7894","DOI":"10.1073\/pnas.90.16.7894","volume":"90","author":"Valentino K.","year":"1993","unstructured":"Valentino K.; Newcomb R.; Gadbois T.; Singh T.; Bowersox S.; Bitner S.; Justice A.; Yamashiro D.; Hoffman B.B.; Ciaranello R.; A selective N-type calcium channel antagonist protects against neuronal loss after global cerebral ischemia. Proc Natl Acad Sci USA 1993,90(16),7894-7897","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=217","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/j.1748-1716.1994.tb09713.x","volume":"150","author":"Zhao Q.","year":"1994","unstructured":"Zhao Q.; Smith M.L.; Siesj\u00f6 B.K.; The omega-conopeptide SNX-111, an N-type calcium channel blocker, dramatically ameliorates brain damage due to transient focal ischaemia. Acta Physiol Scand 1994,150(4),459-461","journal-title":"Acta Physiol Scand"},{"key":"ref=218","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0006-8993(96)01325-X","volume":"747","author":"Bowersox S.S.","year":"1997","unstructured":"Bowersox S.S.; Singh T.; Luther R.R.; Selective blockade of N-type voltage-sensitive calcium channels protects against brain injury after transient focal cerebral ischemia in rats. Brain Res 1997,747(2),343-347","journal-title":"Brain Res"},{"key":"ref=219","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1089\/neu.1998.15.531","volume":"15","author":"Xiong Y.","year":"1998","unstructured":"Xiong Y.; Peterson P.L.; Verweij B.H.; Vinas F.C.; Muizelaar J.P.; Lee C.P.; Mitochondrial dysfunction after experimental traumatic brain injury: combined efficacy of SNX-111 and U-101033E. J Neurotrauma 1998,15(7),531-544","journal-title":"J Neurotrauma"},{"key":"ref=220","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/jcbfm.1995.75","volume":"15","author":"Takizawa S.","year":"1995","unstructured":"Takizawa S.; Matsushima K.; Fujita H.; Nanri K.; Ogawa S.; Shinohara Y.; A selective N-type calcium channel antagonist reduces extracellular glutamate release and infarct volume in focal cerebral ischemia. J Cereb Blood Flow Metab 1995,15(4),611-618","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref=221","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/jcbfm.1994.121","volume":"14","author":"Buchan A.M.","year":"1994","unstructured":"Buchan A.M.; Gertler S.Z.; Li H.; Xue D.; Huang Z.G.; Chaundy K.E.; Barnes K.; Lesiuk H.J.; A selective N-type Ca(2+)-channel blocker prevents CA1 injury 24 h following severe forebrain ischemia and reduces infarction following focal ischemia. J Cereb Blood Flow Metab 1994,14(6),903-910","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref=222","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0022-510X(97)00196-2","volume":"153","author":"Perez-Pinzon M.A.","year":"1997","unstructured":"Perez-Pinzon M.A.; Yenari M.A.; Sun G.H.; Kunis D.M.; Steinberg G.K.; SNX-111, a novel, presynaptic N-type calcium channel antagonist, is neuroprotective against focal cerebral ischemia in rabbits. J Neurol Sci 1997,153(1),25-31","journal-title":"J Neurol Sci"},{"key":"ref=223","first-page":"379","volume":"25","author":"Bowersox S.","year":"1997","unstructured":"Bowersox S.; Mandema J.; Tarczy-Hornoch K.; Miljanich G.; Luther R.R.; Pharmacokinetics of SNX-111, a selective N-type calcium channel blocker, in rats and cynomolgus monkeys. Drug Metab Dispos 1997,25(3),379-383","journal-title":"Drug Metab Dispos"},{"key":"ref=224","first-page":"339","volume":"4","author":"Heading C.E.","year":"2001","unstructured":"Heading C.E.; Ziconotide (Elan Pharmaceuticals). IDrugs 2001,4(3),339-350","journal-title":"IDrugs"},{"key":"ref=225","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2147\/nedt.2007.3.1.69","volume":"3","author":"McGivern J.G.","year":"2007","unstructured":"McGivern J.G.; Ziconotide: a review of its pharmacology and use in the treatment of pain. Neuropsychiatr Dis Treat 2007,3(1),69-85","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref=226","doi-asserted-by":"publisher","first-page":"521","DOI":"10.2147\/TCRM.S4438","volume":"5","author":"Smith H.S.","year":"2009","unstructured":"Smith H.S.; Deer T.R.; Safety and efficacy of intrathecal ziconotide in the management of severe chronic pain. Ther Clin Risk Manag 2009,5(3),521-534","journal-title":"Ther Clin Risk Manag"},{"key":"ref=227","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0896-6273(92)90221-X","volume":"9","author":"Hillyard D.R.","year":"1992","unstructured":"Hillyard D.R.; Monje V.D.; Mintz I.M.; Bean B.P.; Nadasdi L.; Ramachandran J.; Miljanich G.; Azimi-Zoonooz A.; McIntosh J.M.; Cruz L.J.; A new Conus peptide ligand for mammalian presynaptic Ca2+ channels. Neuron 1992,9(1),69-77","journal-title":"Neuron"},{"key":"ref=228","doi-asserted-by":"publisher","first-page":"13804","DOI":"10.1074\/jbc.271.23.13804","volume":"271","author":"Liu H.","year":"1996","unstructured":"Liu H.; De Waard M.; Scott V.E.; Gurnett C.A.; Lennon V.A.; Campbell K.P.; Identification of three subunits of the high affinity omega-conotoxin MVIIC-sensitive Ca2+ channel. J Biol Chem 1996,271(23),13804-13810","journal-title":"J Biol Chem"},{"key":"ref=229","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S0006-8993(98)01214-1","volume":"817","author":"Imaizumi T.","year":"1999","unstructured":"Imaizumi T.; Kocsis J.D.; Waxman S.G.; The role of voltage-gated Ca2+ channels in anoxic injury of spinal cord white matter. Brain Res 1999,817(1-2),84-92","journal-title":"Brain Res"},{"key":"ref=230","first-page":"3524","volume":"7","author":"Oliveira K.M.","year":"2014","unstructured":"Oliveira K.M.; Lavor M.S.; Silva C.M.; Fukushima F.B.; Rosado I.R.; Silva J.F.; Martins B.C.; Guimar\u00e3es L.B.; Gomez M.V.; Melo M.M.; Melo e.g; Omega-conotoxin MVIIC attenuates neuronal apoptosis in vitro and improves significant recovery after spinal cord injury in vivo in rats. Int J Clin Exp Pathol 2014,7(7),3524-3536","journal-title":"Int J Clin Exp Pathol"},{"key":"ref=231","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/0006-8993(90)90366-J","volume":"537","author":"Madden K.P.","year":"1990","unstructured":"Madden K.P.; Clark W.M.; Marcoux F.W.; Probert A.W.; Weber M.L.; Rivier J.; Zivin J.A.; Treatment with conotoxin, an \u2018N-type\u2019 calcium channel blocker, in neuronal hypoxic-ischemic injury. Brain Res 1990,537(1-2),256-262","journal-title":"Brain Res"},{"key":"ref=232","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1113\/jphysiol.1992.sp018919","volume":"445","author":"Wang X.","year":"1992","unstructured":"Wang X.; Treistman S.N.; Lemos J.R.; Two types of high-threshold calcium currents inhibited by omega-conotoxin in nerve terminals of rat neurohypophysis. J Physiol 1992,445,181-199","journal-title":"J Physiol"},{"key":"ref=233","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1042\/bj3430413","volume":"343","author":"Reis H.J.","year":"1999","unstructured":"Reis H.J.; Prado M.A.; Kalapothakis E.; Cordeiro M.N.; Diniz C.R.; De Marco L.A.; Gomez M.V.; Romano-Silva M.A.; Inhibition of glutamate uptake by a polypeptide toxin (phoneutriatoxin 3-4) from the spider Phoneutria nigriventer. Biochem J 1999,343(Pt 2),413-418","journal-title":"Biochem J"},{"key":"ref=234","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.neuint.2006.04.009","volume":"49","author":"Pinheiro A.C.","year":"2006","unstructured":"Pinheiro A.C.; Gomez R.S.; Massensini A.R.; Cordeiro M.N.; Richardson M.; Romano-Silva M.A.; Prado M.A.; De Marco L.; Gomez M.V.; Neuroprotective effect on brain injury by neurotoxins from the spider Phoneutria nigriventer. Neurochem Int 2006,49(5),543-547","journal-title":"Neurochem Int"},{"key":"ref=235","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/sj.bjp.0701381","volume":"122","author":"Guatimosim C.","year":"1997","unstructured":"Guatimosim C.; Romano-Silva M.A.; Cruz J.S.; Beir\u00e3o P.S.; Kalapothakis E.; Moraes-Santos T.; Cordeiro M.N.; Diniz C.R.; Gomez M.V.; Prado M.A.; A toxin from the spider Phoneutria nigriventer that blocks calcium channels coupled to exocytosis. Br J Pharmacol 1997,122(3),591-597","journal-title":"Br J Pharmacol"},{"key":"ref=236","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1097\/00001756-199805110-00022","volume":"9","author":"Miranda D.M.","year":"1998","unstructured":"Miranda D.M.; Romano-Silva M.A.; Kalapothakis E.; Diniz C.R.; Cordeiro M.N.; Santos T.M.; Prado M.A.; Gomez M.V.; Phoneutria nigriventer toxins block tityustoxin-induced calcium influx in synaptosomes. Neuroreport 1998,9(7),1371-1373","journal-title":"Neuroreport"},{"key":"ref=237","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1002\/hipo.20580","volume":"19","author":"Pinheiro A.C.","year":"2009","unstructured":"Pinheiro A.C.; da Silva A.J.; Prado M.A.; Cordeiro, Mdo.N.; Richardson, M.; Batista, M.C.; de Castro Junior, C.J.; Massensini, A.R.; Guatimosim, C.; Romano-Silva, M.A.; Kushmerick, C.; Gomez, M.V. Phoneutria spider toxins block ischemia-induced glutamate release, neuronal death, and loss of neurotransmission in hippocampus. Hippocampus 2009,19(11),1123-1129","journal-title":"Hippocampus"},{"key":"ref=238","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/0041-0101(93)90256-I","volume":"31","author":"Liang S.P.","year":"1993","unstructured":"Liang S.P.; Zhang D.Y.; Pan X.; Chen Q.; Zhou P.A.; Properties and amino acid sequence of huwentoxin-I, a neurotoxin purified from the venom of the Chinese bird spider Selenocosmia huwena. Toxicon 1993,31(8),969-978","journal-title":"Toxicon"},{"key":"ref=239","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.toxicon.2007.07.020","volume":"50","author":"Wang Y.R.","year":"2007","unstructured":"Wang Y.R.; Liu R.Y.; Wang L.C.; Mao H.F.; Chen J.Q.; Effect of Huwentoxin-I on the Fas and TNF apoptosis path-way in the hippocampus of rat with global cerebral ischemia. Toxicon 2007,50(8),1085-1094","journal-title":"Toxicon"},{"key":"ref=240","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0041-0101(93)90354-L","volume":"31","author":"Cordeiro Mdo N.","year":"1993","unstructured":"Cordeiro Mdo N.; de Figueiredo S.G.; Valentim Ado C.; Diniz C.R.; von Eickstedt V.R.; Gilroy J.; Richardson M.; Purification and amino acid sequences of six Tx3 type neurotoxins from the venom of the Brazilian \u2018armed\u2019 spider Phoneutria nigriventer (Keys). Toxicon 1993,31(1),35-42","journal-title":"Toxicon"},{"key":"ref=241","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.toxicon.2011.09.008","volume":"58","author":"de Souza A.H.","year":"2011","unstructured":"de Souza A.H.; Lima M.C.; Drewes C.C.; da Silva J.F.; Torres K.C.; Pereira E.M.; de Castro C.J.; Junior; Vieira, L.B.; Cordeiro, M.N.; Richardson, M.; Gomez, R.S. Romano-Silva, M.A.; Ferreira, J.; Gomez, M.V. Antiallodynic effect and side effects of Ph\u03b11\u03b2, a neurotoxin from the spider Phoneutria nigriventer: comparison with \u03c9 -conotoxin MVIIA and morphine. Toxicon 2011,58(8),626-633","journal-title":"Toxicon"},{"key":"ref=242","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.pbb.2013.10.014","volume":"114-115","author":"Rigo F.K.","year":"2013","unstructured":"Rigo F.K.; Dalmolin G.D.; Trevisan G.; Tonello R.; Silva M.A.; Rossato M.F.; Klafke J.Z.; Cordeiro, Mdo.N.; Castro Junior, C.J.; Montijo, D.; Gomez, M.V.; Ferreira, J. Effect of \u03c9-conotoxin MVIIA and Ph\u03b11\u03b2 on paclitaxel-induced acute and chronic pain. Pharmacol Biochem Behav 2013,114-115,16-22","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=243","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1111\/cas.12209","volume":"104","author":"Rigo F.K.","year":"2013","unstructured":"Rigo F.K.; Trevisan G.; Rosa F.; Dalmolin G.D.; Otuki M.F.; Cueto A.P.; de Castro Junior; Romano-Silva M.A.; Cordeiro, Mdo.N.; Richardson, M.; Ferreira, J.; Gomez, M.V. Spider peptide Ph\u03b11\u03b2 induces analgesic effect in a model of cancer pain. Cancer Sci 2013,104(9),1226-1230","journal-title":"Cancer Sci"},{"key":"ref=244","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.toxicon.2017.05.018","volume":"133","author":"Rigo F.K.","year":"2017","unstructured":"Rigo F.K.; Trevisan G.; De Pra S.D.; Cordeiro M.N.; Borges M.H.; Silva J.F.; Santa Cecilia F.V.; de Souza A.H.; de Oliveira Adamante G.; Milioli A.M.; de Castro C.J.; Junior; Ferreira, J.; Gomez, M.V. The spider toxin Phalpha1beta recombinant possesses strong analgesic activity. Toxicon 2017,133,145-152","journal-title":"Toxicon"},{"key":"ref=245","doi-asserted-by":"publisher","first-page":"9307","DOI":"10.1007\/s12035-018-1049-1","volume":"55","author":"Silva R.B.M.","year":"2018","unstructured":"Silva R.B.M.; Greggio S.; Venturin G.T.; da Costa J.C.; Gomez M.V.; Campos M.M.; Beneficial effects of the calcium channel blocker CTK 01512-2 in a mouse model of multiple sclerosis. Mol Neurobiol 2018,55(12),9307-9327","journal-title":"Mol Neurobiol"},{"key":"ref=246","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1161\/01.STR.8.1.51","volume":"8","author":"Astrup J.","year":"1977","unstructured":"Astrup J.; Symon L.; Branston N.M.; Lassen N.A.; Cortical evoked potential and extracellular K+ and H+ at critical levels of brain ischemia. Stroke 1977,8(1),51-57","journal-title":"Stroke"},{"key":"ref=247","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.cell.2004.08.026","volume":"118","author":"Xiong Z.G.","year":"2004","unstructured":"Xiong Z.G.; Zhu X.M.; Chu X.P.; Minami M.; Hey J.; Wei W.L.; MacDonald J.F.; Wemmie J.A.; Price M.P.; Welsh M.J.; Simon R.P.; Neuroprotection in ischemia: blocking calcium-permeable acid-sensing ion channels. Cell 2004,118(6),687-698","journal-title":"Cell"},{"key":"ref=248","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/jcbfm.2010.30","volume":"30","author":"Li M.","year":"2010","unstructured":"Li M.; Inoue K.; Branigan D.; Kratzer E.; Hansen J.C.; Chen J.W.; Simon R.P.; Xiong Z.G.; Acid-sensing ion channels in acidosis-induced injury of human brain neurons. J Cereb Blood Flow Metab 2010,30(6),1247-1260","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref=249","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.nbd.2008.05.008","volume":"31","author":"Arias R.L.","year":"2008","unstructured":"Arias R.L.; Sung M.L.; Vasylyev D.; Zhang M.Y.; Albinson K.; Kubek K.; Kagan N.; Beyer C.; Lin Q.; Dwyer J.M.; Zaleska M.M.; Bowlby M.R.; Dunlop J.; Monaghan M.; Amiloride is neuroprotective in an MPTP model of Parkinson\u2019s disease. Neurobiol Dis 2008,31(3),334-341","journal-title":"Neurobiol Dis"},{"key":"ref=250","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/brain\/awl325","volume":"130","author":"Pignataro G.","year":"2007","unstructured":"Pignataro G.; Simon R.P.; Xiong Z.G.; Prolonged activation of ASIC1a and the time window for neuroprotection in cerebral ischaemia. Brain 2007,130(Pt 1),151-158","journal-title":"Brain"},{"key":"ref=251","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.nbd.2011.04.018","volume":"43","author":"Yang Z.J.","year":"2011","unstructured":"Yang Z.J.; Ni X.; Carter E.L.; Kibler K.; Martin L.J.; Koehler R.C.; Neuroprotective effect of acid-sensing ion channel inhibitor psalmotoxin-1 after hypoxia-ischemia in newborn piglet striatum. Neurobiol Dis 2011,43(2),446-454","journal-title":"Neurobiol Dis"},{"key":"ref=252","doi-asserted-by":"publisher","first-page":"25116","DOI":"10.1074\/jbc.M003643200","volume":"275","author":"Escoubas P.","year":"2000","unstructured":"Escoubas P.; De Weille J.R.; Lecoq A.; Diochot S.; Waldmann R.; Champigny G.; Moinier D.; M\u00e9nez A.; Lazdunski M.; Isolation of a tarantula toxin specific for a class of proton-gated Na+ channels. J Biol Chem 2000,275(33),25116-25121","journal-title":"J Biol Chem"},{"key":"ref=253","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1124\/mol.111.072207","volume":"80","author":"Saez N.J.","year":"2011","unstructured":"Saez N.J.; Mobli M.; Bieri M.; Chassagnon I.R.; Malde A.K.; Gamsjaeger R.; Mark A.E.; Gooley P.R.; Rash L.D.; King G.F.; A dynamic pharmacophore drives the interaction between Psalmotoxin-1 and the putative drug target acid-sensing ion channel 1a. Mol Pharmacol 2011,80(5),796-808","journal-title":"Mol Pharmacol"},{"key":"ref=254","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.neuropharm.2015.08.040","volume":"99","author":"McCarthy C.A.","year":"2015","unstructured":"McCarthy C.A.; Rash L.D.; Chassagnon I.R.; King G.F.; Widdop R.E.; PcTx1 affords neuroprotection in a conscious model of stroke in hypertensive rats via selective inhibition of ASIC1a. Neuropharmacology 2015,99,650-657","journal-title":"Neuropharmacology"},{"key":"ref=255","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1093\/abbs\/gmu067","volume":"46","author":"Sun X.","year":"2014","unstructured":"Sun X.; Jin J.; Zhang J.G.; Qi L.; Braun F.K.; Zhang X.D.; Xu F.; Expression of acid-sensing ion channels in nucleus pulposus cells of the human intervertebral disk is regulated by non-steroid anti-inflammatory drugs. Acta Biochim Biophys Sin (Shanghai) 2014,46(9),774-781","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"ref=256","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.gene.2017.11.034","volume":"642","author":"Zhou R.P.","year":"2018","unstructured":"Zhou R.P.; Ni W.L.; Dai B.B.; Wu X.S.; Wang Z.S.; Xie Y.Y.; Wang Z.Q.; Yang W.J.; Ge J.F.; Hu W.; Chen F.H.; ASIC2a overexpression enhances the protective effect of PcTx1 and APETx2 against acidosis-induced articular chondrocyte apoptosis and cytotoxicity. Gene 2018,642,230-240","journal-title":"Gene"},{"key":"ref=257","doi-asserted-by":"publisher","first-page":"3750","DOI":"10.1073\/pnas.1614728114","volume":"114","author":"Chassagnon I.R.","year":"2017","unstructured":"Chassagnon I.R.; McCarthy C.A.; Chin Y.K.; Pineda S.S.; Keramidas A.; Mobli M.; Pham V.; De Silva T.M.; Lynch J.W.; Widdop R.E.; Rash L.D.; King G.F.; Potent neuroprotection after stroke afforded by a double-knot spider-venom peptide that inhibits acid-sensing ion channel 1a. Proc Natl Acad Sci USA 2017,114(14),3750-3755","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=258","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1021\/acs.jproteome.7b00686","volume":"17","author":"Liao Q.","year":"2018","unstructured":"Liao Q.; Li S.; Siu S.W.I.; Yang B.; Huang C.; Chan J.Y.; Morlighem J.R.L.; Wong C.T.T.; R\u00e1dis-Baptista G.; Lee S.M.; Novel kunitz-like peptides discovered in the Zoanthid Palythoa caribaeorum through transcriptome sequencing. J Proteome Res 2018,17(2),891-902","journal-title":"J Proteome Res"},{"key":"ref=259","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.2174\/1381612003399653","volume":"6","author":"Jones R.M.","year":"2000","unstructured":"Jones R.M.; Bulaj G.; Conotoxins - new vistas for peptide therapeutics. Curr Pharm Des 2000,6(12),1249-1285","journal-title":"Curr Pharm Des"},{"key":"ref=260","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1016\/S0041-0101(98)00156-1","volume":"36","author":"Harvey A.L.","year":"1998","unstructured":"Harvey A.L.; Bradley K.N.; Cochran S.A.; Rowan e.g.; Pratt J.A.; Quillfeldt J.A.; Jerusalinsky D.A.; What can toxins tell us for drug discovery? Toxicon 1998,36(11),1635-1640","journal-title":"Toxicon"},{"key":"ref=261","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"Dauer W.","year":"2003","unstructured":"Dauer W.; Przedborski S.; Parkinson\u2019s disease: mechanisms and models. Neuron 2003,39(6),889-909","journal-title":"Neuron"},{"key":"ref=262","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/S0361-9230(01)00773-0","volume":"57","author":"Isacson O.","year":"2002","unstructured":"Isacson O.; Models of repair mechanisms for future treatment modalities of Parkinson\u2019s disease. Brain Res Bull 2002,57(6),839-846","journal-title":"Brain Res Bull"},{"key":"ref=263","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1038\/nm.2224","volume":"16","author":"Jucker M.","year":"2010","unstructured":"Jucker M.; The benefits and limitations of animal models for translational research in neurodegenerative diseases. Nat Med 2010,16(11),1210-1214","journal-title":"Nat Med"},{"key":"ref=264","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-61779-433-9_1","volume":"824","author":"Fahnert B.","year":"2012","unstructured":"Fahnert B.; Using folding promoting agents in recombinant protein production: a review. Methods Mol Biol 2012,824,3-36","journal-title":"Methods Mol Biol"},{"key":"ref=265","first-page":"53","volume":"267","author":"Fahnert B.","year":"2004","unstructured":"Fahnert B.; Folding-promoting agents in recombinant protein production. Methods Mol Biol 2004,267,53-74","journal-title":"Methods Mol Biol"},{"key":"ref=266","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3389\/fmicb.2014.00172","volume":"5","author":"Rosano G.L.","year":"2014","unstructured":"Rosano G.L.; Ceccarelli E.A.; Recombinant protein expression in Escherichia coli: advances and challenges. Front Microbiol 2014,5,172","journal-title":"Front Microbiol"},{"key":"ref=267","doi-asserted-by":"publisher","DOI":"10.3791\/52431","author":"Stefan A.","year":"2015","unstructured":"Stefan A.; Ceccarelli A.; Conte E.; Monton Silva A.; Hochkoeppler A.; The multifaceted benefits of protein co-expression in Escherichia coli. J Vis Exp 10.3791\/524312015(96)","journal-title":"J Vis Exp"},{"key":"ref=268","first-page":"257","volume":"3","author":"Khan K.H.","year":"2013","unstructured":"Khan K.H.; Gene expression in mammalian cells and its applications. Adv Pharm Bull 2013,3(2),257-263","journal-title":"Adv Pharm Bull"},{"key":"ref=269","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1073\/pnas.96.4.1181","volume":"96","author":"Miranda L.P.","year":"1999","unstructured":"Miranda L.P.; Alewood P.F.; Accelerated chemical synthesis of peptides and small proteins. Proc Natl Acad Sci USA 1999,96(4),1181-1186","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=270","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/978-1-4939-6737-7_3","volume":"1548","author":"M\u00fcnzker L.","year":"2017","unstructured":"M\u00fcnzker L.; Oddo A.; Hansen P.R.; Chemical synthesis of antimicrobial peptides. Methods Mol Biol 2017,1548,35-49","journal-title":"Methods Mol Biol"},{"key":"ref=271","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1021\/ja003265m","volume":"123","author":"Yan L.Z.","year":"2001","unstructured":"Yan L.Z.; Dawson P.E.; Synthesis of peptides and proteins without cysteine residues by native chemical ligation combined with desulfurization. J Am Chem Soc 2001,123(4),526-533","journal-title":"J Am Chem Soc"},{"key":"ref=272","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/psc.2880","volume":"22","author":"Engelhard M.","year":"2016","unstructured":"Engelhard M.; Quest for the chemical synthesis of proteins. J Pept Sci 2016,22(5),246-251","journal-title":"J Pept Sci"},{"key":"ref=273","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.sbi.2014.03.002","volume":"26","author":"Hojo H.","year":"2014","unstructured":"Hojo H.; Recent progress in the chemical synthesis of proteins. Curr Opin Struct Biol 2014,26,16-23","journal-title":"Curr Opin Struct Biol"},{"key":"ref=274","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1146\/annurev.biophys.34.040204.144700","volume":"34","author":"Nilsson B.L.","year":"2005","unstructured":"Nilsson B.L.; Soellner M.B.; Raines R.T.; Chemical synthesis of proteins. Annu Rev Biophys Biomol Struct 2005,34,91-118","journal-title":"Annu Rev Biophys Biomol Struct"},{"key":"ref=275","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1021\/bi00815a005","volume":"9","author":"Ferreira S.H.","year":"1970","unstructured":"Ferreira S.H.; Bartelt D.C.; Greene L.J.; Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom. Biochemistry 1970,9(13),2583-2593","journal-title":"Biochemistry"},{"key":"ref=276","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0079-6468(08)70157-7","volume":"17","author":"Cushman D.W.","year":"1980","unstructured":"Cushman D.W.; Ondetti M.A.; Inhibitors of angiotensin-converting enzyme. Prog Med Chem 1980,17,41-104","journal-title":"Prog Med Chem"},{"key":"ref=277","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/j.1463-1326.2008.01018.x","volume":"11","author":"Gentilella R.","year":"2009","unstructured":"Gentilella R.; Bianchi C.; Rossi A.; Rotella C.M.; Exenatide: a review from pharmacology to clinical practice. Diabetes Obes Metab 2009,11(6),544-556","journal-title":"Diabetes Obes Metab"},{"key":"ref=278","first-page":"401","volume":"4","author":"Nielsen L.L.","year":"2003","unstructured":"Nielsen L.L.; Baron A.D.; Pharmacology of exenatide (synthetic exendin-4) for the treatment of type 2 diabetes. Curr Opin Investig Drugs 2003,4(4),401-405","journal-title":"Curr Opin Investig Drugs"},{"key":"ref=279","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.toxicon.2010.12.016","volume":"59","author":"Furman B.L.","year":"2012","unstructured":"Furman B.L.; The development of Byetta (exenatide) from the venom of the Gila monster as an anti-diabetic agent. Toxicon 2012,59(4),464-471","journal-title":"Toxicon"},{"key":"ref=280","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1331\/154434506775268698","volume":"46","author":"Triplitt C.","year":"2006","unstructured":"Triplitt C.; Chiquette E.; Exenatide: from the Gila monster to the pharmacy. J. Am. Pharm. Assoc. (2003), 2006,46(1),44-52"},{"key":"ref=281","doi-asserted-by":"publisher","first-page":"4022","DOI":"10.1073\/pnas.86.11.4022","volume":"86","author":"Garsky V.M.","year":"1989","unstructured":"Garsky V.M.; Lumma P.K.; Freidinger R.M.; Pitzenberger S.M.; Randall W.C.; Veber D.F.; Gould R.J.; Friedman P.A.; Chemical synthesis of echistatin, a potent inhibitor of platelet aggregation from Echis carinatus: synthesis and biological activity of selected analogs. Proc Natl Acad Sci USA 1989,86(11),4022-4026","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=282","first-page":"192","volume":"13","author":"Hashemzadeh M.","year":"2008","unstructured":"Hashemzadeh M.; Furukawa M.; Goldsberry S.; Movahed M.R.; Chemical structures and mode of action of intravenous glycoprotein IIb\/IIIa receptor blockers: a review. Exp Clin Cardiol 2008,13(4),192-197","journal-title":"Exp Clin Cardiol"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/166802","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,4]],"date-time":"2022-09-04T19:55:40Z","timestamp":1662321340000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/166802\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,16]]},"references-count":282,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2019,10,16]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867325666181031122438","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10,16]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-08-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}